2021

Rook, G.A.W. (2021). Comment on Parker et al. (Evolution, Medicine and Public Health 2021;9:120-30.).. Evolution, medicine, and public health, 9 (1), 192-193. doi:10.1093/emph/eoab011
Rook, G.A.W., Bloomfield, S.F. (2021). Microbial exposures that establish immunoregulation are compatible with Targeted Hygiene. Journal of Allergy and Clinical Immunology, doi:10.1016/j.jaci.2021.05.008

2020

Langgartner, D., Zambrano, C.A., Heinze, J.D., Stamper, C.E., Boebel, T.S., Hackl, S.B., ...Guendel, H. (2020). Association of the Salivary Microbiome With Animal Contact During Early Life and Stress-Induced Immune Activation in Healthy Participants. FRONTIERS IN PSYCHIATRY, 11 doi:10.3389/fpsyt.2020.00353

2019

Smith, D.G., Martinelli, R., Besra, G.S., Illarionov, P.A., Szatmari, I., Brazda, P., ...Nagy, L. (2019). Identification and characterization of a novel anti-inflammatory lipid isolated from Mycobacterium vaccae, a soil-derived bacterium with immunoregulatory and stress resilience properties. Psychopharmacology, 236 (5), 1653-1670. doi:10.1007/s00213-019-05253-9

2018

Boebel, T.S., Hackl, S.B., Langgartner, D., Jarczok, M.N., Rohleder, N., Rook, G.A., ...Reber, S.O. (2018). Less immune activation following social stress in rural vs. urban participants raised with regular or no animal contact, respectively. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 115 (20), 5259-5264. doi:10.1073/pnas.1719866115
Ossola, A., Egerer, M.H., Lin, B.B., Rook, G., Setala, H. (2018). Lost food narratives can grow human health in cities. FRONTIERS IN ECOLOGY AND THE ENVIRONMENT, 16 (10), 560-562. doi:10.1002/fee.1977
Flandroy, L., Poutahidis, T., Berg, G., Clarke, G., Dao, M.-.C., Decaestecker, E., ...Plovier, H. (2018). The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems. SCIENCE OF THE TOTAL ENVIRONMENT, 627 1018-1038. doi:10.1016/j.scitotenv.2018.01.288

2017

Rook, G., Backhed, F., Levin, B.R., McFall-Ngai, M.J., McLean, A.R. (2017). Evolution, human-microbe interactions, and life history plasticity. LANCET, 390 (10093), 521-530. doi:10.1016/S0140-6736(17)30566-4

2016

Garn, H., Bahn, S., Baune, B.T., Binder, E.B., Bisgaard, H., Chatila, T.A., ...Gay, S. (2016). Current concepts in chronic inflammatory diseases: Interactions between microbes, cellular metabolism, and inflammation. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 138 (1), 47-56. doi:10.1016/j.jaci.2016.02.046
Reber, S.O., Siebler, P.H., Donner, N.C., Morton, J.T., Smith, D.G., Kopelman, J.M., ...Hassell, J.E. (2016). Immunization with a heat-killed preparation of the environmental bacterium Mycobacterium vaccae promotes stress resilience in mice.. Proceedings of the National Academy of Sciences of the United States of America, 113 (22), E3130-E3139. doi:10.1073/pnas.1600324113
Camacho, F., Sarmiento, M.E., Reyes, F., Kim, L., Huggett, J., Lepore, M., ...Norazmi, M.N. (2016). Selection of phage-displayed human antibody fragments specific for CD1b presenting the Mycobacterium tuberculosis glycolipid Ac2SGL.. International journal of mycobacteriology, 5 (2), 120-127. doi:10.1016/j.ijmyco.2015.12.002
Stamper, C.E., Hoisington, A.J., Gomez, O.M., Halweg-Edwards, A.L., Smith, D.G., Bates, K.L., ...Rook, G.A.W. (2016). The Microbiome of the Built Environment and Human Behavior: Implications for Emotional Health and Well-Being in Postmodern Western Societies. GUT MICROBIOME AND BEHAVIOR, 131 289-323. doi:10.1016/bs.irn.2016.07.006
Lowry, C.A., Smith, D.G., Siebler, P.H., Schmidt, D., Stamper, C.E., Hassell, J.E., ...Brenner, L.A. (2016). The Microbiota, Immunoregulation, and Mental Health: Implications for Public Health.. Current environmental health reports, 3 (3), 270-286. doi:10.1007/s40572-016-0100-5
Bloomfield, S.F., Rook, G.A.W., Scott, E.A., Shanahan, F., Stanwell-Smith, R., Turner, P. (2016). Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene. PERSPECTIVES IN PUBLIC HEALTH, 136 (4), 213-224. doi:10.1177/1757913916650225

2015

von Hertzen, L., Beutler, B., Bienenstock, J., Blaser, M., Cani, P.D., Eriksson, J., ...Jenmalm, M.C. (2015). Helsinki alert of biodiversity and health. ANNALS OF MEDICINE, 47 (3), 218-225. doi:10.3109/07853890.2015.1010226
Rook, G.A.W., Lowry, C.A., Raison, C.L. (2015). Hygiene and other early childhood influences on the subsequent function of the immune system.. BRAIN RESEARCH, 1617 47-62. doi:10.1016/j.brainres.2014.04.004
Marshall, S., Milne, G., Rook, G., Timmerman, R. (2015). Walking – a step change towards healthy cities. Town and Country Planning, 125-129.

2014

Rook, G.A.W., Raison, C.L., Lowry, C.A. (2014). Microbial 'old friends', immunoregulation and socioeconomic status.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 177 (1), 1-12. doi:10.1111/cei.12269
Rook, G.A.W., Raison, C.L., Lowry, C.A. (2014). Microbiota, immunoregulatory old friends and psychiatric disorders.. MICROBIAL ENDOCRINOLOGY: THE MICROBIOTA-GUT-BRAIN AXIS IN HEALTH AND DISEASE, 817 319-356. doi:10.1007/978-1-4939-0897-4_15

2013

Rook, G.A.W., Raison, C.L., Lowry, C.A. (2013). Childhood microbial experience, immunoregulation, inflammation and adult susceptibility to psychosocial stressors and depression in rich and poor countries.. Evolution, medicine, and public health, 2013 (1), 14-17. doi:10.1093/emph/eos005
Rook, G.A.W., Lowry, C.A., Raison, C.L. (2013). Microbial 'Old Friends', immunoregulation and stress resilience.. Evolution, medicine, and public health, 2013 (1), 46-64. doi:10.1093/emph/eot004
Camacho, F., Huggett, J., Kim, L., Infante, J.F., Lepore, M., Perez, V., ...Acosta, A. (2013). Phage display of functional αβ single-chain T-cell receptor molecules specific for CD1b:Ac₂SGL complexes from Mycobacterium tuberculosis-infected cells.. BMC IMMUNOLOGY, 14 doi:10.1186/1471-2172-14-S1-S2
Rook, G.A. (2013). Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health.. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110 (46), 18360-18367. doi:10.1073/pnas.1313731110
Olivares, N., Marquina, B., Mata-Espinoza, D., Zatarain-Barron, Z.L., Pinzón, C.E., Estrada, I., ...Hernandez-Pando, R. (2013). The protective effect of immunoglobulin in murine tuberculosis is dependent on IgG glycosylation.. PATHOGENS AND DISEASE, 69 (3), 176-183. doi:10.1111/2049-632X.12069

2012

Rook, G.A.W., Raison, C.L., Lowry, C.A. (2012). Can we vaccinate against depression?. DRUG DISCOVERY TODAY, 17 (9-10), 451-458. doi:10.1016/j.drudis.2012.03.018
Barrios-Payán, J., Saqui-Salces, M., Jeyanathan, M., Alcántara-Vazquez, A., Castañon-Arreola, M., Rook, G., Hernandez-Pando, R. (2012). Extrapulmonary locations of mycobacterium tuberculosis DNA during latent infection.. JOURNAL OF INFECTIOUS DISEASES, 206 (8), 1194-1205. doi:10.1093/infdis/jis381
Rook, G.A.W. (2012). Hygiene hypothesis and autoimmune diseases.. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 42 (1), 5-15. doi:10.1007/s12016-011-8285-8
Hale, M.W., Rook, G.A.W., Lowry, C.A. (2012). Pathways underlying afferent signaling of bronchopulmonary immune activation to the central nervous system.. Chemical immunology and allergy, 98 118-141. doi:10.1159/000336505
Luzina, I.G., Keegan, A.D., Heller, N.M., Rook, G.A.W., Shea-Donohue, T., Atamas, S.P. (2012). Regulation of inflammation by interleukin-4: a review of "alternatives".. JOURNAL OF LEUKOCYTE BIOLOGY, 92 (4), 753-764. doi:10.1189/jlb.0412214

2011

Mendez, A., Hernandez-Pando, R., Contreras, S., Aguilar, D., Rook, G.A.W. (2011). CCL2, CCL18 and sIL-4R in renal, meningeal and pulmonary TB; a 2 year study of patients and contacts.. TUBERCULOSIS, 91 (2), 140-145. doi:10.1016/j.tube.2010.12.008
Le Bert, N., Chain, B.M., Rook, G., Noursadeghi, M. (2011). DC priming by M. vaccae inhibits Th2 responses in contrast to specific TLR2 priming and is associated with selective activation of the CREB pathway.. PLOS ONE, 6 (4), doi:10.1371/journal.pone.0018346
Rook, G.A.W. (2011). Hygiene and other early childhood influences on the subsequent function of the immune system.. DIGESTIVE DISEASES, 29 (2), 144-153. doi:10.1159/000323877
Rook, G.A.W., Dalgleish, A. (2011). Infection, immunoregulation, and cancer.. IMMUNOLOGICAL REVIEWS, 240 141-159. doi:10.1111/j.1600-065X.2010.00987.x
Rook, G.A.W., Lowry, C.A., Raison, C.L. (2011). Lymphocytes in neuroprotection, cognition and emotion: is intolerance really the answer?. BRAIN BEHAVIOR AND IMMUNITY, 25 (4), 591-601. doi:10.1016/j.bbi.2010.12.005
Abebe, M., Kim, L., Rook, G., Aseffa, A., Wassie, L., Zewdie, M., ...Doherty, T.M. (2011). Modulation of cell death by M. tuberculosis as a strategy for pathogen survival.. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, doi:10.1155/2011/678570

2010

Rook, G.A.W. (2010). 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: darwinian medicine and the 'hygiene' or 'old friends' hypothesis.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 160 (1), 70-79. doi:10.1111/j.1365-2249.2010.04133.x
Pooran, A., Booth, H., Miller, R.F., Scott, G., Badri, M., Huggett, J.F., ...Dheda, K. (2010). Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis.. BMC PULMONARY MEDICINE, 10 doi:10.1186/1471-2466-10-7
Rook, G.A.W. (2010). Evolved dependence of the human immune system on microbial Old Friends..
Abebe, M., Doherty, T.M., Wassie, L., Aseffa, A., Bobosha, K., Demissie, A., ...Kim, L. (2010). Expression of apoptosis-related genes in an Ethiopian cohort study correlates with tuberculosis clinical status.. EUROPEAN JOURNAL OF IMMUNOLOGY, 40 (1), 291-301. doi:10.1002/eji.200939856
Raison, C.L., Lowry, C.A., Rook, G.A.W. (2010). Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression.. ARCHIVES OF GENERAL PSYCHIATRY, 67 (12), 1211-1224. doi:10.1001/archgenpsychiatry.2010.161
Rook, G.A.W. (2010). The gut, immunoregulation and micro-organisms from man's evolutionary past. Nutrition bulletin., 35 (2), 102-112. doi:10.1111/j.1467-3010.2010.01823.x
Rakotosamimanana, N., Raharimanga, V., Andriamandimby, S.F., Soares, J.-.L., Doherty, T.M., Ratsitorahina, M., ...Rook, G. (2010). Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar.. CLINICAL AND VACCINE IMMUNOLOGY, 17 (7), 1094-1103. doi:10.1128/CVI.00049-10

2009

Churchyard, G.J., Kaplan, G., Fallows, D., Wallis, R.S., Onyebujoh, P., Rook, G.A. (2009). Advances in immunotherapy for tuberculosis treatment.. CLINICS IN CHEST MEDICINE, 30 (4), 769-+. doi:10.1016/j.ccm.2009.08.009
Witt, N., Rodger, G., Vandesompele, J., Benes, V., Zumla, A., Rook, G.A., Huggett, J.F. (2009). An assessment of air as a source of DNA contamination encountered when performing PCR.. Journal of Biomolecular Techniques, 20 (5), 236-240.
Rook, G.A.W., Doherty, T.M. (2009). Host susceptibility and resistance to Mycobacterium tuberculosis; Genetic, Neuroendocrine, and acquired factors. In Schaaf, H.S., Zumla, A. (Eds.), Tuberculosis. W B Saunders Co.
Rook, G.A.W. (2009). Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis.. IMMUNOLOGY, 126 (1), 3-11. doi:10.1111/j.1365-2567.2008.03007.x
Rook, G.A.W. (2009). The changing microbial environment, Darwinian Medicine and the hygiene hypothesis. In The hygiene hypothesis and Darwinian Medicine. Basel: Birkhäuser.
Rook, G.A.W. (2009). The changing microbial environment, Darwinian Medicine and the hygiene hypothesis. In The hygiene hypothesis and Darwinian Medicine. Basel: Birkhäuser.
Rook, G.A.W., Lowry, C.A. (2009). The hygiene hypothesis and affective and anxiety disorders. In Rook, G.A.W. (Ed.), The Hygiene Hypothesis and Darwinian Medicine. Birkhauser.
Armelagos, G.J., Harper, K.N., Campbell, A.R., Rook, G.A. (2009). The Paleolithic Disease-scape, the Hygiene Hypothesis, and the Second Epidemiological Transition..

2008

Wassie, L., Demissie, A., Aseffa, A., Abebe, M., Yamuah, L., Tilahun, H., ...Andersen, A. (2008). Ex vivo cytokine mRNA levels correlate with changing clinical status of Ethiopian TB patients and their contacts over time. PLoS ONE, 3 e1522-.
Dheda, K., Chan, J.S., Lala, S., Hugget, J.F., Zumla, A., Rook, G. (2008). Gene expression of IL17 and IL23 in the lungs of patients with active tuberculosis.. Thorax, 63 (6), 566-568.
Hernández-Pando, R., Aguilar, D., Orozco, H., Cortez, Y., Rosa Brunet, L., Rook, G.A.W. (2008). Immunotherapeutic effect of oral Mycobacterium vaccae on pulmonary tuberculosis in BALB/c mice; modulation of expression of molecules involved in immunoregulation. Clinical and Vaccine Immunology,
Pulimood, A.B., Peter, S., Rook, G.A.W., Donoghue, H.D. (2008). In situ PCR for Mycobacterium tuberculosis in endoscopic mucosal biopsies of intestinal tuberculosis and Crohn disease. American Journal of Clinical Pathology, 129 846-851.
Hernandez-Pando, R., Aguilar, D., Orozco, H., Cortez, Y., Brunet, L.R., Rook, G.A. (2008). Orally Administered Mycobacterium vaccae Modulates Expression of Immunoregulatory Molecules in BALB/c Mice with Pulmonary Tuberculosis. CLINICAL AND VACCINE IMMUNOLOGY, 15 (11), 1730-1736. doi:10.1128/CVI.00286-08
Rook, G.A.W., Witt, N. (2008). Probiotics and other organisms in Allergy and Autoimmune Diseases. In Versalovic, J., Wilson, M. (Eds.), Therapeutic microbiology. Amer Society for Microbiology.
Rook, G., Witt, N. (2008). Probiotics and other organisms in allergy and autoimmune diseases. In Versalovic, J., Wilson, M. (Eds.), Therapeutic microbiology: probiotics and related strategies. (pp. 231-247). Washington DC: ASM Press.
Davies, P.D.O., Yew, W.W., Ganguly, D., Davidow, A.L., Reichman, L.B., Dheda, K., Rook, G.A.W. (2008). Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 100 291-298. doi:10.1016/j.trstmh.2005.06.034
Rook, G.A.W. (2008). The changing microbial environment and chronic inflammatory disorders. Allergy, Asthma and Clinical Immunology, 4 doi:10.2310/7480.2008.00013
Rook, G.A. (2008). The changing microbial environment and chronic inflammatory disorders.. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 4 (3), 117-124. doi:10.1186/1710-1492-4-3-117
Rook, G.A.W., Lowry, C.A. (2008). The hygiene hypothesis and psychiatric disorders. Trends in Immunology, 29 150-158.

2007

Rook, G.A.W. (2007). Endocrine and cytokine responses in humans with pulmonary tuberculosis. Brain, Behavior, and Immunity, 21 (2), 169-170. doi:10.1016/j.bbi.2006.08.003
Burl, S., Hill, P.C., Jeffries, D.J., Holland, M.J., Fox, A., Lugos, M.D., ...McAdam, K.P. (2007). FOXP3 gene expression in a tuberculosis case contact study. Clinical and Experimental Immunology, [Epub ahead of p
Lowry, C.A., Hollis, J.H., de Vries, A., Pan, B., Brunet, R., Hunt, J.R., ...Evans, A.K. (2007). Identification of an immune-responsive mesolimbocortical serotonergic system: potential in regulation of emotional behaviour. Neuroscience, 146 (2), 756-772.
Lowry, C.A., Hollis, J.H., de Vries, A., Pan, B., Brunet, L.R., Hunt, J.R.F., ...Evans, A.K. (2007). Identification of an immune-responsive mesolimbocortical serotonergic system: potential role in regulation of emotional behavior.. NEUROSCIENCE, 146 (2), 756-772. doi:10.1016/j.neuroscience.2007.01.067
Rook, G.A.W., Lowrie, D.B., Hernandez Pando, R. (2007). Immunotherapeutics for tuberculosis in experimental animals; is a common pathway activated by effective protocols. The Journal of Infectious Diseases, 196 191-198.
Dheda, K., Pooran, A., Pai, M., Miller, R.F., Lesley, K., Booth, H.L., ...Rook, G.A. (2007). Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results. Journal of Infection, 55 (2), 169-173.
Rook, G.A.W., Hamelmann, E., Rosa Brunet, L. (2007). Mycobacteria and allergies. Immunobiology, 212 (6), 461-473. doi:10.1016/j.imbio.2007.03.003
Rook, G.A.W. (2007). Stop TB: a long way to go, but new twists and turns in the science. Indian Journal of Medical Research, 125 109-111.
Rook, G.A.W. (2007). Th2 cytokines in susceptibility to tuberculosis. Current Molecular Medicine, 7 (3), 327-337.
Rook, G.A.W. (2007). The hygiene hypothesis and the increamng prevalence of chronic inflammatory disorders. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 101 (11), 1072-1074. doi:10.1016/j.trstmh.2007.05.014
Rook, G.A.W. (2007). The hygiene hypothesis and the increasing prevalence of chronic inflammatory disorders. Transactions of the Royal Society of Tropical Medicine and Hygiene, 101 1072-1074.
Lala, S., Dheda, K., Chang, J.S., Huggett, J.F., Kim, L.U., Johnson, M.A., ...Zumla, A. (2007). The pathogen recognition sensor, NOD2, is variably expressed in patients with pulmonary tuberculosis. BMC Infectious Diseases, 7 96-.
Dheda, K., Chang, J., S, H., J F, K., L U, J., M A, Z., ...G, A.W. (2007). The stability of mRNA encoding IL-4 is increased in pulmonary tuberculosis, while stability of mRNA encoding the antagonistic splice variant, IL-4delta2, is not. Tuberculosis, 87 237-241.

2006

Rook, G., Kim, L.U. (2006). Comments on the new analysis of the Chingleput BCG trial. Indian Journal of Medical Research, 123 (20), 103-106.
Chang, J.S., Dheda, K., Huggett, J.F., Kim, L.U., Zumla, A., Rook, G.A. (2006). Expression of IL-4 mRNA in peripheral blood mononuclear cells from normal donors in relation to expression of TLR2. Immunology Letters, 106 (20), 194-197.
Rook, G., Dheda, K., Zumla, A. (2006). Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not. Tuberculosis (Edinb), 86 152-162.
Berth-Jones, J., Arkwright, P.D., Marasovic, D., Savani, N., Aldridge, C.R., Leech, S.N., ...Chopra, S. (2006). Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Clinical and Experimental Allergy, 36 (9), 1115-1121.
Berth-Jones, J., Arkwright, P.D., Marasovic, D., Savani, N., Aldridge, C.R., Leech, S.N., ...Chopra, S. (2006). Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis: A randomized, double-blind, placebo-controlled trial. Clinical and Experimental Allergy, 36 (9), 1115-1121. doi:10.1111/j.1365-2222.2006.02558.x
Berth-Jones, J., Arkwright, P.D., Marasovic, D., Savani, N., Aldridge, C.R., Leech, S.N., ...Chopra, S. (2006). Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial. CLINICAL AND EXPERIMENTAL ALLERGY, 36 (9), 1115-1121. doi:10.1111/j.1365-2222.2006.02558.x
Chang, J.-.S., Huggett, J.F., Dheda, K., Kim, L.U., Zumla, A., Rook, G. (2006). M. tuberculosis induces selective upregulation of Toll-like receptors in the mononuclear leukocytes of patients with active pulmonary tuberculosis. The Journal of Immunology, 176 (5), 3010-3018.
Guarner, F.B.-.S., R Brandtzaeg, P.G., H S, M., P, V.E., W, V., J, W., ......G. (2006). Mechanisms of disease: the hygiene hypothesis revisited. Nature Clinical Practice Gastroenterology and Hepatology, 3 (5), 275-284.
Chang, J.-.S., Huggett, J.F., Dheda, K., Kim, L.U., Zumla, A., Rook, G.A.W. (2006). Myobacterium tuberculosis induces selective up-regulation of TLRs in the mononuclear leukocytes of patients with active pulmonary tuberculosis.. JOURNAL OF IMMUNOLOGY, 176 (5), 3010-3018. doi:10.4049/jimmunol.176.5.3010
Doherty, T.M., Rook, G. (2006). Progress and hindrances in tuberculosis vaccine development. The Lancet, 367 947-949.
Demissie, A., Leyten, E.M., Abebe, M., Wassie, L., Aseffa, A., Abate, G., ...Brookes, R. (2006). Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clinical and Vaccine Immunology, 13 (20), 179-186.
Davies, P.D.O., Yew, W.W., Ganguly, D., Davidow, A.L., Reichman, L.B., Dheda, K., Rook, G.A. (2006). Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 100 (4), 291-298. doi:10.1016/j.trstmh.2005.06.034
Demissie, A., Wassie, L., Abebe, M., Aseffa, A., Rook, G., Zumla, A., ...Doherty, T.M. (2006). The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon. Infection and Immunity, 74 (5), 2817-2822.
Demissie, A., Wassie, L., Abebe, M., Aseffa, A., Rook, G., Zumla, A., ...Doherty, T.M. (2006). The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon. INFECTION AND IMMUNITY, 74 (5), 2817-2822. doi:10.1128/IAI.74.5.2817-2822.2006
Ruddick, J.P., Evans A K, N., D J, L., S L Rook, G., Lowry, C.A. (2006). Tryptophan metabolism in the central nervous system: medical implications. Expert Reviews in Molecular Medicine, 8 (20), 1-27.
Ruddick, J.P., Evans, A.K., Nutt, D.J., Lightman, S.L., Rook, G.A.W., Lowry, C.A. (2006). Tryptophan metabolism in the central nervous system: medical implications.. Expert reviews in molecular medicine, 8 (20), 1-27. doi:10.1017/s1462399406000068

2005

Dheda, K., Chang, J.S., Breen, R.A., Kim, L.U., Haddock, J.A., Huggett, J.F., ...Zumla, A. (2005). In vivo and in vitro studies of a novel cytokine, interleukin-4delta2, in pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine, 172 (4), 501-508. doi:10.1164/rccm.200502-278OC
Hernandez-Pando, R., Aguilar-Leon, D., Orozco, H., Serrano, A., Ahlem, C., Trauger, R., ...Rook, G.A. (2005). 16alpha-bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis. The Journal of Infectious Diseases, 191 (2), 299-306.
Rook, G.A.W., Brunet, L.R. (2005). Chronic inflammatory disorders, the gut and the 'Old Friends' hypothesis.
Thapa, N., Rook, G.A.W., Donoghue, H., Stanford, J.L. (2005). Detection of intracellular TNF-α and IL-10 in CD4 and CD8 cells of patients with pulmonary tuberculosis using a flow cytometer. SAARC Journal of Tuberculosis, Lung Diseases & HIV/AIDS, 2 (1), 10-14.
Rook, G.A.W., Dheda, K., Zumla, A. (2005). Do successful tuberculosis vaccines need to be immunoregulatory rather thanmerely Th1-boosting?. Vaccine, 23 (17-18), 2115-2120. doi:10.1016/j.vaccine.2005.01.069
Doherty, T.M., Demissie, A., Menzies, D., Anderson, P., Rook, G., Zumla, A. (2005). Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR.. Journal of Microbiological Methods, 298 (1-2), 129-141.
Dheda, K., Chang, J.S., Breen, R.A., Haddock, J.A., Huggett, J.F., Lipman, M.C., ...Zumla, A. (2005). Expression of a novel cytokine, IL-4delta2, in HIV and HIV-tuberculosis co-infection. AIDS, 19 (15), 1601-1606.
Lu, P.D., Patel, M.J., Yosipovitch, G., Martiniuk, F., Cabrera, A., Levis, W.R. (2005). HIV and leprosy in the eastern United States. JOURNAL OF INFECTIOUS DISEASES, 192 (9), 1673-1674. doi:10.1086/496992
Rook, G.A.W., Dheda, K., Zumla, A. (2005). Immune responses to TB in developing countries: implications for new vaccines. Nature Reviews Immunology, 5 (8), 661-667. doi:10.1038/nri1666
Lalvani, A., Richeldi, L., Kunst, H. (2005). Interferon gamma assays for tuberculosis. LANCET INFECTIOUS DISEASES, 5 (6), 322-324. doi:10.1016/S1473-3099(05)70118-3
Dheda, K., Chang, J.S., Kim, L.U., Huggett, J.F., Johnson, M.A., Zumla, A., Rook, G.A.W. (2005). Interferon gamma assays for tuberculosis. The Lancet Infectious Diseases, 5 (6), 324-325. doi:10.1016/S1473-3099(05)70119-5
Hunt, J.R., Martinelli, R., Adams, V.C., Rook, G.A., Brunet, L.R. (2005). Intragastric administration of Mycobacterium vaccae inhibits severe pulmonary allergic inflammation in a mouse model.. Clinical and Experimental Allergy, 35 (5), 685-690.
Dheda, K., Booth, H., Huggett, J.F., Johnson, M.A., Zumla, A., Rook, G.A.W. (2005). Lung remodeling in pulmonary tuberculosis.. JOURNAL OF INFECTIOUS DISEASES, 192 (7), 1201-1210. doi:10.1086/444545
Dheda, K., Booth, H., Huggett, J.F., Johnson, M.A., Zumla, A., Rook, G.A.W. (2005). Lung remodelling in tuberculosis. The Journal of Infectious Diseases, 192 (7), 1201-1210.
Rook, G.A.W., Brunet, L.R. (2005). Microbes, immunoregulation, and the gut.. Gut, 54 (3), 317-320.
Rook, G.A., Martinelli, R., Brunet, L.R. (2005). Modelling gene-environment interactions in Th1- and Th2-dominated diseases of laboratory animals. Ernst Schering Research Foundation Workshop, 50 45-68.
Rook, G.A.W. (2005). Old Friends and homoeostasis.
Rook, G.A.W., Brunet, L.R. (2005). Old friends for breakfast. Clinical and Experimental Allergy, 35 841-842.
Dheda, K., Lalvani, A., Miller, R.F., Scott, G., Booth, H., Johnson, M.A., ...Rook, G.A. (2005). Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS, 9 (17), 2038-2041.
Dheda, K., Lampe, F., Lipman, M.C., Johnson, M.A., Rook, G.A. (2005). Reply to Lu et al. The Journal of Infectious Diseases, 192 (9), 1674-1675.
Rook, G.A.W., Martinelli, R., Rosa Brunet, L. (2005). The "Old Friends" hypothesis: how early contact with certain microorganisms may influence regulatory circuits. In Hodgson, D.M., Coe, C.L. (Eds.), Perinatal Programming: Early Life Determinants of Adult Health and Disease. (pp. 183-194). London and New York: Taylor and Francis.
Dheda, K., Huggett, J.F., Chang, J.S., Kim, L.U., Bustin, S.A., Johnson, M.A., ...Zumla, A. (2005). The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization. Analytical Biochemistry, 344 (1), 141-143. doi:10.1016/j.ab.2005.05.022
Thapa, N., Lydyard, P., Rook, G.A.W., Stanford, J.L. (2005). The proportions of CD4, CD8, CD3 T cells in peripheral circulation of patients with pulmonary tuberculosis. SAARC Journal of Tuberculosis, Lung Diseases & HIV/AIDS, 2 (1), 23-28.
Dheda, K., Udwadia, Z.F., Huggett, J.F., Johnson, M.A., Rook, G.A. (2005). Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. Current Opinion in Pulmonary Medicine, 11 (3), 195-202.

2004

Adams, V.C., Hunt, J.R., Martinelli, R., Palmer, R., Rook, G.A., Brunet, L.R. (2004). Mycobacterium vaccae induces a population of pulmonary CD11c+ cells with regulatory potential in allergic mice. European Journal of Immunology, 34 (3), 631-638.
Huggett, J., Dheda, K., Zumla, A., Rook, G. (2004). Crohn's disease and MAP. The Lancet, 364 (9452), 2178.
Huggett, J., Dheda, K., Zumla, A., Rook, G., Naser, S.A., Valentine, J.F., ...MacKenzie, J.F. (2004). Crohn's disease and MAP [4] (multiple letters). Lancet, 364 (9452), 2178-2179. doi:10.1016/S0140-6736(04)17585-5
Huggett, J., Dheda, K., Zumla, A., Rook, G. (2004). edicine 10:157-158. 11. Huggett J, Dheda K, Zumla A, Rook G.. The Lancet, 364 2178-2179.
Demissie, A., Abebe, M., Aseffa, A., Rook, G., Fletcher, H., Zumla, A., ...Doherty, T.M. (2004). Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th 1 cytokines and the IL-4 antagonist IL-4delta2. The Journal of Immunology, 172 (11), 6938-6943.
Dheda, K., Rook, G. (2004). Higher tuberculosis mortality in India seen in those who have ever smoked. Thorax, 59 (2), 115. doi:10.1136/thx.2003.la72
Dheda, K., Huggett, J.F., Kim, L.U., Breen, R., Haddock, J.A., Johnson, M.A., ...Rook, G.A.W. (2004). IL-4 Delta 2 and Th2 cytokines in human pulmonary tuberculosis.
Rook, G.A., Hernandez-Pando, R., Dheda, K., Teng Seah, G. (2004). IL-4 in tuberculosis: implications for vaccine design. Trends in Immunology, 25 (9), 483-488.
Fletcher, H.A., Owiafe, P., Jeffries, D., Hill, P., Rook, G.A., Zumla, A., ...Brookes RH Vacsel Study, G.R.O.U.P. (2004). Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation.. Immunology, 112 (4), 669-673.
Rook, G.A., Adams, V., Hunt, J., Palmer, R., Martinelli, R., Brunet, L.R. (2004). Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders. Springer Seminars in Immunopathology, 25 (3-4), 237-255.
Dheda, K., Rook, G., Zumla, A. (2004). Peripheral T Cell Interferon-{gamma} Responses and Latent Tuberculosis. American Journal of Respiratory and Critical Care Medicine, 170 (1), 97-98.
Dheda, K., Rook, G., Zumla, A., Mori, T. (2004). Peripheral T cell interferon-γ responses and latent tuberculosis [5] (multiple letters). American Journal of Respiratory and Critical Care Medicine, 170 (1), 97-98.
Hernandez-Pando, R., Aguilar, D., Hernandez, M.L., Orozco, H., Rook, G. (2004). Pulmonary tuberculosis in BALB/c mice with non-functional IL-4 genes: changes in the inflammatory effects of TNF-alpha and in the regulation of fibrosis. European Journal of Immunology, 34 (1), 174-183. doi:10.1002/eji.200324253
Dheda, K., Johnson, M.A., Zumla, A., Rook, G.A. (2004). Smoking is not beneficial for tuberculosis. American Journal of Respiratory and Critical Care Medicine, 170 (7), 821.
Dheda, K., Johnson, M.A., Zumla, A., Rook, G.A. (2004). Smoking is Not Beneficial for Tuberculosis. American Journal of Respiratory and Critical Care Medicine, 170 (7), 821. doi:10.1164/ajrccm.170.7.950
Dheda, K., Johnson, M.A., Zumla, A., Rook, G.A., Maier, L.A. (2004). Smoking is not beneficial for tuberculosis (multiple letters). American Journal of Respiratory and Critical Care Medicine, 170 (7), 821-. doi:10.1164/ajrccm.170.7.950
Rook, G.A.W. (2004). The Immunology and Pathogenesis of Tuberculosis. In Madkour, M.M. (Ed.), Tuberculosis. (pp. 133-151). Berlin: Springer.
Onyebujoh, P., Rook, G.A.W., Roscigno, G., Rustomjee, R., Zumla, A. (2004). Tuberculosis. Nature Reviews Microbiology, 2 (12), 930-932.
Dheda, K., Huggett, J.F., Bustin, S.A., Johnson, M.A., Rook, G., Zumla, A. (2004). Validation of housekeeping genes for normalizing RNA expression in real-time PCR. BioTechniques, 37 (1), 112, 116,-114, 116,.
Dheda, K., Huggett, J.F., Bustin, S.A., Johnson, M.A., Rook, G., Zumla, A. (2004). Validation of housekeeping genes for normalizing RNA expression in real-time PCR.. BIOTECHNIQUES, 37 (1), 112-+. doi:10.2144/04371RR03

2003

Martinelli, R., Hunt, J.R.F., Rook, G.A.W., Rosa Brunet, L. (2003). Effects of Mycobacterium vaccae on peritoneal exudate cells of napve mice.
Walker, C., Sawicka, E., Rook, G.A.W. (2003). Immunotherapy with mycobacteria. Current Opinion in Allergy and Clinical Immunology, 3 (6), 481-486.
Rook, G.A.W., Martinelli, R., Brunet, L.R. (2003). Innate immune responses to mycobacteria and the downregulation of atopic responses. Current Opinion in Allergy and Clinical Immunology, 3 (5), 337-342.
Adams, V.C., Hunt, J.R.F., Martinelli, R., Palmer, R., Rook, G.A.W., Rosa Brunet, L. (2003). Mycobacterium vaccae induces a CD11c+ population that produces regulatory cytokines in the lungs of allergic mice.
Breivik, T., Rook, G.A.W. (2003). Oral treatment with SRP299 (killed Mycobacterium vaccae) inhibits experimental periodontal disease in Wistar rats. Journal of Clinical Periodontology, 30 (11), 931-936.
Camporota, L., Corkhill, A., Long, H., Lordan, J., Stanciu, L., Tuckwell, N., ...Holgate, S.T. (2003). The effects of Mycobacterium vaccae on allergen-induced air responses in atopic asthma. European Respiratory Journal, 21 (2), 287-293.

2002

Rook, G.A., Lightman, S.L., Heijnen, C.J. (2002). Can nerve damage disrupt neuroendocrine immune homeostasis? Leprosy as a case in point. Trends in Immunology, 23 (1), 18-22.
Rook, G.A.W., Lightman, S.L., Heijnen, C.J. (2002). Can nerve damage disrupt neuroendocrine immune homeostasis? Leprosy as a case in point.. TRENDS IN IMMUNOLOGY, 23 (1), 18-22. doi:10.1016/S1471-4906(01)02090-7
Rosa Brunet, L., Hunt, J., Rook, G.A.W. (2002). Dangers of therapeutic manipulation of the Th1--Th2 balance. Trends in Immunology, 23 (3), 127-128.
Adams, V.C., Hunt, J.R., Rosa Brunet, L., Rook, G.A.W. (2002). Effect of Mycobacterium vaccae on ICOS expression in a murine model.
Rook, G.A.W., Rosa Brunet, L. (2002). Give us this day our daily germs. Biologist, 49 (4), 145-149.
Arriaga, A.K., Orozco, E.H., Aguilar, L.D., Rook, G.A., Hernandez, P.R. (2002). Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clinical and Experimental Immunology, 128 (2), 229-237.
Rook, G.A.W. (2002). Immunoregulation: the hygiene hypothesis and the brain.
Zuany-Amorim, C., Manlius, C., Trifilieff, A., Rosa Brunet, L., Rook, G., Bowen, G., ...Walker, C. (2002). Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. The Journal of Immunology, 169 (3), 1492-1499.
Rook, G.A.W., Rosa Brunet, L., Hunt, J. (2002). Multiple consequences of the changing educational input to our immune systems. In Heidt, P.J., Midtvedt, T., Rusch, V., van der Waaij, D. (Eds.), Probiotics: Bacteria and Bacterial Fragments as Immunomodulatory Agents. (pp. 35-53). Herborn-Dill, Germany: Institut f+r Integrative Biologie GmbH.
Stansby, G., Chan, Y.C., Berwanger, C.S., Shurey, S., Rook, G.A., Stanford, J.L. (2002). Prevention of experimental myointimal hyperplasia by immunomodulation. European Journal of Vascular and Endovascular Surgery, 23 (1), 23-28.
Zuany-Amorim, C., Sawicka, E., Manlius, C., Le Moine, A., Rosa Brunet, L., Kemeny, D.M., ...Walker, C. (2002). Suppression of airway eosinophilia by killed Mycobacterium vaccae- induced allergen-specific regulatory T-cells. Nature Medicine, 8 (6), 625-629.
Druilhe, P., Hagan, P., Rook, G.A.W. (2002). The importance of models of infection in the study of disease resistance. Trends in Microbiology, 10 (10 (Su), S38-S46.
Brelvik, T., Rook, G.A. (2002). Treatment with SRL172 (heat-killed Mycobacterium vaccae) inhibits progression of established experimental periodontal disease in Wistar rats. Journal of Periodontal Research, 37 (3), 210-214.

2001

Rook, G.A., Zumla, A. (2001). Advances in the immunopathogenesis of pulmonary tuberculosis. Current Opinion in Pulmonary Medicine, 7 (3), 116-123.
Rook, G.A., Rosa-Brunet, L., Hunt, J. (2001). Cat allergen and sensitisation. The Lancet, 357 (9274), 2137-2138.
Seah, G.T., Rook, G.A. (2001). High levels of mRNA encoding IL-4 in unstimulated peripheral blood mononuclear cells from tuberculosis patients revealed by quantitative nested reverse transcriptase-polymerase chain reaction; correlations with serum IgE levels. Scandinavian Journal of Infectious Diseases, 33 (2), 106-109.
Seah, G.T., Rook, G.A. (2001). Il-4 influences apoptosis of mycobacterium-reactive lymphocytes in the presence of TNF-alpha. The Journal of Immunology, 167 (3), 1230-1237.
Seah, G.T., Gao, P.S., Hopkin, J.M., Rook, G.A. (2001). Interleukin-4 and its alternatively spliced variant (IL-4delta2) in patients with atopic asthma. American Journal of Respiratory and Critical Care Medicine, 164 (6), 1016-1018.
Rook, G.A., Seah, G., Ustianowski, A. (2001). M. tuberculosis: immunology and vaccination. European Respiratory Journal, 17 (3), 537-557.
Rook, G. (2001). Th1-or Th2-cell commitment during infectious disease: an oversimplification?. TRENDS IN IMMUNOLOGY, 22 (9), 481. doi:10.1016/S1471-4906(01)01980-9
Everest, P., Wain, J., Roberts, M., Rook, G., Dougan, G. (2001). The molecular mechanisms of severe typhoid fever. TRENDS IN MICROBIOLOGY, 9 (7), 316-320. doi:10.1016/S0966-842X(01)02067-4
Rook, G.A.W. (2001). The role of mycobacteria in the education of the developing immune system. CLINICAL AND EXPERIMENTAL ALLERGY, 31 (1), 165.
Rook, G.A. (2001). The TGF-beta1 paradox in asthma. Trends in Immunology, 22 (6), 299-300.

2000

Rook, G.A., Ristori, G., Salvetti, M., Giovannoni, G., Thompson, E.J., Stanford, J.L. (2000). Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune disorders. Immunology Today, 21 (10), 503-508.
Rook, G.A. (2000). Clean Living increases more than just atopic disease. Immunology Today, 21 (5), 249-250.
Amiel, C., Kusnierz, J.P., Mouton, Y., Rook, G.A., Stanford, J.L., Singh, M., ...Bahr, G.M. (2000). Cytokine analysis and the single cell level and lymphoproliferative responses to mycobacterial antigens in HIV-1 patients with successful virologic response to potent antiretrovirals. Journal of Clinical Immunology, 20 (6), 458-465.
Baker, R.W., Walker, B.R., Shaw, R.J., Honour, J.W., Jessop, D.S., Lightman, S.L., ...Rook, G.A. (2000). Increased cortisol: cortisone ratio in acute pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine, 162 (5), 1641-1647.
Baker, R.W., Walker, B.R., Shaw, R.J., Honour, J.W., Jessop, D.S., Lightman, S.L., ...Rook, G.A. (2000). Increased cortisol: cortisone ratio in acute pulmonary tuberculosis.. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 162 (5), 1641-1647. doi:10.1164/ajrccm.162.5.9912119
Hernandez-Pando, R., Pavon, L., Orozco, E.H., Rangel, J., Rook, G.A. (2000). Interactions between hormone-mediated and vaccine-mediated immunotherapy for pulmonary tuberculosis in BALB/c mice. Immunology, 100 (3), 391-398.
Rook, G., Baker, R., Walker, B., Honour, J., Jessop, D., Hernandez-Pando, R., ...Lightman, S. (2000). Local regulation of glucocorticoid activity in sites of inflammation. Insights from the study of tuberculosis. Annals of the New York Academy of Sciences, 917 913-922.
Hernandez-Pando, R., Jeyanathan, M., Mengistu, G., Aguilar, D., Orozco, H., Harboe, M., ...Bjune, G. (2000). Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. The Lancet, 356 (9248), 2133-2138.
Breivik, T., Rook, G.A. (2000). Prevaccination with SRL172 (heat-killed Mycobacterium vaccae) inhibits experimental periodontal disease in Wistar rats. Clinical and Experimental Immunology, 120 (3), 463-467.
Hernandez-Pando, R., Orozco, E.H., Arriaga, K., Pavon, L., Rook, G.A. (2000). Treatment with BB-94, a broad spectrum inhibitor of zinc-dependent metalloproteinases, causes deviation of the cytokine profile towards type-2 in experimental pulmonary tuberculosis in Balb/c mice. International Journal of Experimental Pathology, 81 (3), 199-209.
Seah, G.T., Scott, G.M., Rook, G.A. (2000). Type 2 cytokine gene activation and its relationship to the extent of disease in patients with tuberculosis. The Journal of Infectious Diseases, 181 (1), 385-389.

1999

Seah, G.T., Rook, G.A.W. (1999). A sensitive, non-radioactive quantitative method for measuring IL-4 and IL-4 delta 2 mRNA in unstimulated cells from multiple clinical samples, using nested RT-PCR. JOURNAL OF IMMUNOLOGICAL METHODS, 228 (1-2), 139-149. doi:10.1016/S0022-1759(99)00084-8
Leirisalo-Repo, M., Hernandez-Munoz, H.E., Rook, G.A.W. (1999). Agalactosyl IgG is elevated in patients with active spondyloarthropathy. RHEUMATOLOGY INTERNATIONAL, 18 (5-6), 171-176. doi:10.1007/s002960050080
Rook, G.A., Baker, R. (1999). Cortisol metabolism, cortisol sensitivity and the pathogenesis of leprosy reactions.. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 4 (7), 493-498. doi:10.1046/j.1365-3156.1999.00432.x
Rook, G.A. (1999). Glucocorticoids and immune function.. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 13 (4), 567-581. doi:10.1053/beem.1999.0044
Onyebujoh, P.C., Levin, J.B., Fourie, F.B., Garhiram, V., Tembe, L.C., Phili, N.P., ...Ramajoe, I.M. (1999). Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. LANCET, 354 (9173), 116-119.
Maraveyas, A., Baban, B., Kennard, D., Rook, G.A.W., Westby, M., Grange, J.M., ...Selby, P. (1999). Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: Correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes. ANNALS OF ONCOLOGY, 10 (7), 817-824. doi:10.1023/A:1008307821189
Rook, G.A.W., Stanford, J.L. (1999). Skin-test responses to mycobacteria in atopy and asthma. ALLERGY, 54 (3), 285-286. doi:10.1034/j.1398-9995.1999.00107.x
Zumla, A., Rook, G., Mwaba, P., Lucas, S. (1999). Tuberculosis. In James, D.G., Zumla, A. (Eds.), Granulmatous Disorders. (pp. 132-160). Cambridge, UK: Cambridge University Press.

1998

Leirisalo-Repo, M., Hernandez-Munoz, H., Paimela, L., Rook, G.A.W. (1998). Agalactosyl IGG is a prognostic marker in early rheumatoid arthritis.. ARTHRITIS AND RHEUMATISM, 41 (9), S272.
Trao, V.T., Huong, P.L.T., Thuan, A.T., Anh, D.D., Trach, D.D., Rook, G.A.W., Wright, E.P. (1998). Changes in cellular response to mycobacterial antigens and cytokine production patterns in leprosy patients during multiple drug therapy. IMMUNOLOGY, 94 (2), 197-206. doi:10.1046/j.1365-2567.1998.00485.x
Hernandez-Pando, R., de la Luz Streber, M., Orozco, H., Arriaga, K., Pavon, L., Marti, O., ...Rook, G.A. (1998). Emergent immunoregulatory properties of combined glucocorticoid and anti-glucocorticoid steroids in a model of tuberculosis.. QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 91 (11), 755-766. doi:10.1093/qjmed/91.11.755
Russell, D., Rook, G.A.W., Blackwell, J.M., Kaplan, G., Wadee, A.A., Orme, I., ...Ress, S. (1998). Endocytic trafficking and the mycobacterial vacuole - General discussion I.
Rook, G. (1998). Give us this day our daily germs. Immunology Today, 19 (3), 113-116. doi:10.1016/s0167-5699(97)01204-8
Rook, G.A., Stanford, J.L. (1998). Give us this day our daily germs.. IMMUNOLOGY TODAY, 19 (3), 113-116. doi:10.1016/S0167-5699(97)01204-8
Rook, G.A., Hernandez-Pando, R. (1998). Immunological and endocrinological characteristics of tuberculosis that provide opportunities for immunotherapeutic intervention.. GENETICS AND TUBERCULOSIS, 217 73-98. doi:10.1002/0470846526.ch6
Wang, C.C., Rook, G.A. (1998). Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae.. IMMUNOLOGY, 93 (3), 307-313.
Rook, G.A., Zumla, A. (1998). Is the Gulf War syndrome an immunologically mediated phenomenon?. HOSPITAL MEDICINE, 59 (1), 10-11.
Rook, G.A., Zumla, A. (1998). Is the Gulf War syndrome an immunologically mediated phenomenon? [editorial]. Hospital Medicine, 59 (1), 10-11.
Kon, O.M., Goyal, M., Filley, E., Gleissberg, G., Cunningham, D., Rook, G.A.W., Shaw, R.J. (1998). Mycobacterium vaccae: a study of safety and outcome measures. RESPIRATORY MEDICINE, 92 (3), 597-598. doi:10.1016/S0954-6111(98)90316-X
Converse, P.J., Dannenberg, A.M., Shigenaga, T., Mcmurray, D.N., Phalen, S.W., Stanford, J.L., ...Estep, J.E. (1998). Pulmonary bovine-type tuberculosis in rabbits: Bacillary virulence, inhaled dose effects, tuberculin sensitivity, and Mycobacterium vaccae immunotherapy. Clinical and Diagnostic Laboratory Immunology, 5 (6), 871-881. doi:10.1128/cdli.5.6.871-881.1998
Converse, P.J., Dannenberg, A.M., Shigenaga, T., McMurray, D.N., Phalen, S.W., Stanford, J.L., ...Estep, J.E. (1998). Pulmonary bovine-type tuberculosis in rabbits: Bacillary virulence, inhaled dose effects, tuberculin sensitivity, and Mycobacterium vaccae immunotherapy. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 5 (6), 871-881. doi:10.1128/CDLI.5.6.871-881.1998
Hernandez-Pando, R., Streber, M.D.L., Orozco, H., Arriaga, K., Pavon, L., Al-Nakhli, S.A., Rook, G.A.W. (1998). The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice. IMMUNOLOGY, 95 (2), 234-241.

1997

Baker, R., Rook, G.A., Zumla, A. (1997). Adrenal function and the hypothalamo-pituitary adrenal axis in immunodeficiency virus-associated tuberculosis. International Journal of Tuberculosis and Lung Disease, 1 (3), 289-291.
Baker, R., Rook, G.A.W., Zumla, A. (1997). Adrenal function and the hypothalamo-pituitary adrenal axis in immunodeficiency virus-associated tuberculosis. International Journal of Tuberculosis and Lung Disease, 1 (3), 289-291.
Baker, R., Shaw, R.J., Rook, G.A.W., Honour, J., Lightman, S.L., Walker, B.R., Zumla, A. (1997). Are there subtle abnormalities of glucocorticoid metabolism in active pulmonary tuberculosis which affect immune responses?.
Baker, R., Shaw, R.J., Rook, G.A.W., Honour, J., Lightman, S.L., Walker, B.R., Zumla, A. (1997). Glucocorticoids and Acute Pulmonary Tuberculosis: a clue to pathogenesis?.
Rook, G.A., Zumla, A. (1997). Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile?. The Lancet, 349 (9068), 1831-1833.
Fakoya, A., Matear, P.M., Filley, E., Rook, G.A.W., Stanford, J., Gilson, R.J.C., ...Vyakarnam, A. (1997). HIV infection alters the production of both type 1 and type 2 cytokines but does not induce a polarised type 1 or type 2 state. AIDS, 11 (12), 1445-1452. doi:10.1097/00002030-199712000-00008
Rook, G.A.W., Hernandez-Pando, R., Baker, R., Orozco, H., Arriaga, K., Pavol, L., Streber, M. (1997). Human and murine tuberculosis as models for immuno-endocrine interactions. In Rook, G.A.W., Lightman, S. (Eds.), Steroid hormones and the T cell cytokine profile. (pp. 193-220). London: Springer.
Rook, G.A.W., Hernandez-Pando, R., Stanford, J.L. (1997). Immunotherapy of intracellular infections. In Van der Meer, J.W.M., Michel, M.F., Verbrugh, H.A. (Eds.), New Approaches to Intracellular Bacterial Infections. (pp. 95-106). The Hague: SmithKline Beecham Farma b.v..
Hernandez-Pando, R., Pavon, L., Arriaga, K., Orozco, H., Madrid-Marina, V., Rook, G.A.W. (1997). Improvement and exacerbation of murine tuberculosis by previous exposure to low and high doses of an environmental mycobacterial saprophyte. Infection and Immunity, 65 3310-3316.
Rook, G.A.W. (1997). Intractable mycobacterial infections associated with genetic defects in the receptor for interferon gamma: what does this tell us about immunity to mycobacteria?. Thorax, 52 S41-S46.
Gaora, P.O., Barnini, S., Hayward, C., Filley, E., Rook, G., Young, D., Thole, J. (1997). Mycobacteria as immunogens: Development of expression vectors for use in multiple mycobacterial species. MEDICAL PRINCIPLES AND PRACTICE, 6 (2), 91-96.
HernandezPando, R., Pavon, L., Arriaga, K., Orozco, H., MadridMarina, V., Rook, G. (1997). Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection. INFECTION AND IMMUNITY, 65 (8), 3317-3327. doi:10.1128/IAI.65.8.3317-3327.1997
Hernandez-Pando, R., Pavon, L., Arriaga, K., Orozco, H., Madrid-Marina, V., Rook, G.A.W. (1997). Pathogenesis of tuberculosis in mice exposed tolow and high doses of an environmental mycobacterial saprophyte. INFECT IMMUN, (65), 3310-3316.
Rook, G.A.W., Hernandez-Pando, R. (1997). Pathogenetic role in human and murine tuberculosis of changes in the peripheral metabolism of glucocorticoids and antiglucocorticoids. Psychoneuroendocrinology, 22 S109-S113.
Baker, R., Shaw, R.J., Rook, G.A.W., Honour, J., Lightman, S.L., Walker, B.R., Zumla, A. (1997). Patients with acute pulmonary tuberculosis (Tb) have subtle abnormalities of glucocorticoid metabolism which may affect immune responses.
Baker, R., Shaw, R.J., Rook, G.A.W., Honour, J., Lightman, S.L., Walker, B.R., Zumla, A. (1997). Patients with acute pulmonary tuberculosis (Tb) have subtle but crucial abnormalities of steroid metabolism which may persist after cure or be constitutive.
Stanford, J.L., Rook, G.A.W. (1997). Potential immunotherapy for tuberculosis and future potential for HIV. In Zumla, A., Johnson, M., Miller, R. (Eds.), AIDS and respiratory medicine. (pp. 375-393). London: Chapman & Hall Medical.
Rook, G.A.W., HernandezPando, R., Stanford, J.L. (1997). Protection and immunopathology in tuberculosis: The role of immunotherapy. JOURNAL OF PHARMACY AND PHARMACOLOGY, 49 47-51. doi:10.1111/j.2042-7158.1997.tb06150.x
Rook, G.A.W., Baker, R., Zumla, A. (1997). Steroid Metabolism and Immunity. BioDrugs, 8 (3), 157-163. doi:10.2165/00063030-199708030-00001
Rook, G.A.W., Baker, R., Zumla, A. (1997). Steroid metabolism and immunity: therapeutic implications. BioDrugs, 8 (3), 157-163.
Rook, G.A., Baker, R., Zumla, A. (1997). Steroid metabolism and immunity: therapeutic implications. Biodrugs, 8 3.
Rook, G.A.W., Hernandez-Pando, R. (1997). The influence of adrenal steroids on macrophage and T-cell function in tuberculosis. In Bendinelli, M., Paradise, L.J., Friedman, H. (Eds.), Opportunistic Intracellular Pathogens and Immunity. New York: Plenum Publishing Corp.
Rook, G.A.W., HernandezPando, R., Baker, R. (1997). The potential of the endocrine system for tuberculosis therapy. JOURNAL OF PHARMACY AND PHARMACOLOGY, 49 43-46. doi:10.1111/j.2042-7158.1997.tb06149.x
Rook, G.A.W., Hernandez-Pando, R., Baker, R. (1997). The potential of the endocrine system for tuberculosis therapy. J PHARM PHARMACOL, 49 (1), 43-46.
Khosravi, A.D., Stanford, J.L., Donoghue, H.D., Rook, G.A. (1997). Variation within Mycobacterium scrofulaceum. Journal of Applied Microbiology, 83 (5), 596-602.

1996

Donald, P.R., Beyers, N., Rook, G.A.W. (1996). Adolescent tuberculosis. SOUTH AFRICAN MEDICAL JOURNAL, 86 (3), 231-233.
Pilkington, C., Taylor, P.V., Silverman, E., Isenberg, D.A., Costello, A.M., Rook, G.A. (1996). Agalactosyl IgG and materno-fetal transmission of autoimmune neonatal lupus.. RHEUMATOLOGY INTERNATIONAL, 16 (3), 89-94. doi:10.1007/BF01409979
Rook, G.A.W., HernandezPando, R. (1996). Cellular immune responses in tuberculosis: Protection and immunopathology.
Groenink, J., Spijker, J., vandenHerikOudijk, I.E., Boeije, L., Rook, G., Aarden, L., ...vandenBroek, M.F. (1996). On the interaction between agalactosyl IgG and Fc gamma receptors. EUROPEAN JOURNAL OF IMMUNOLOGY, 26 (6), 1404-1407. doi:10.1002/eji.1830260634
Pilkington, C., Basaran, M., Barlan, I., Costello, A.M., Rook, G.A. (1996). Raised levels of agalactosyl IgG in childhood tuberculosis.. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 90 (2), 167-168. doi:10.1016/S0035-9203(96)90124-8
Rook, G.A., Stanford, J.L. (1996). The Koch phenomenon and the immunopathology of tuberculosis.. TUBERCULOSIS, 215 239-262.
Rook, G.A., Hernandez-Pando, R. (1996). The pathogenesis of tuberculosis.. ANNUAL REVIEW OF MICROBIOLOGY, 50 259-284. doi:10.1146/annurev.micro.50.1.259
Baker, R.W., Zumla, A., Rook, G.A.W. (1996). Tuberculosis, steroid metabolism and immunity. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 89 (5), 387-394.
Rook, G.A.W., Honour, J., Kon, O.M., Wilkinson, R.J., Davidson, R., Shaw, R.J. (1996). Urinary adrenal steroid metabolites in tuberculosis - A new clue to pathogenesis?. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 89 (5), 333-341.

1995

Rook, G.A., Stanford, J.L. (1995). Adjuvants, endocrines and conserved epitopes; factors to consider when designing "therapeutic vaccines".. INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 17 (2), 91-102. doi:10.1016/0192-0561(94)00091-2
HERNANDEZPANDO, R., OROZCO, H., HONOUR, J., SILVA, P., LEYVA, R., ROOK, G.A.W. (1995). ADRENAL CHANGES IN MURINE PULMONARY TUBERCULOSIS - A CLUE TO PATHOGENESIS. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 12 (1), 63-72. doi:10.1016/0928-8244(95)00051-8
Hernandez-Pando, R. (1995). Adrenal changes in murine pulmonary tuberculosis; a clue to pathogenesis?. FEMS Immunology and Medical Microbiology, 12 (1), 63-72. doi:10.1016/0928-8244(95)00051-8
Pilkington, C., Yeung, E., Isenberg, D., Lefvert, A.K., Rook, G.A. (1995). Agalactosyl IgG and antibody specificity in rheumatoid arthritis, tuberculosis, systemic lupus erythematosus and myasthenia gravis.. AUTOIMMUNITY, 22 (2), 107-111. doi:10.3109/08916939508995306
McCulloch, J., Zhang, Y.W., Dawson, M., Harkiss, G.D., Peterhans, E., Vogt, H.R., ...Rook, G.A. (1995). Glycosylation of IgG during potentially arthritogenic lentiviral infections.. RHEUMATOLOGY INTERNATIONAL, 14 (6), 243-248. doi:10.1007/BF00262090
Onyebujoh, P.C., Abdulmumini, T., Robinson, S., Rook, G.A., Stanford, J.L. (1995). Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa.. Respiratory medicine, 89 (3), 199-207. doi:10.1016/0954-6111(95)90248-1
ONYEBUJOH, P.C., ABDULMUMINI, T., ROBINSON, S., ROOK, G.A.W., STANFORD, J.L. (1995). IMMUNOTHERAPY WITH MYCOBACTERIUM-VACCAE AS AN ADDITION TO CHEMOTHERAPY FOR THE TREATMENT OF PULMONARY TUBERCULOSIS UNDER DIFFICULT CONDITIONS IN AFRICA. RESPIRATORY MEDICINE, 89 (3), 199-207. doi:10.1016/0954-6111(95)90248-1
Pilkington, C., Lefvert, A.K., Rook, G.A. (1995). Neonatal myasthenia gravis and the role of agalactosyl IgG.. AUTOIMMUNITY, 21 (2), 131-135. doi:10.3109/08916939508993361
Polla, B.S., Baladi, S., Fuller, K., Rook, G. (1995). Presence of hsp65 in bacterial extracts (OM-89): a possible mediator of orally-induced tolerance?. EXPERIENTIA, 51 (8), 775-779. doi:10.1007/BF01922429
GRANGE, J.M., STANFORD, J.L., ROOK, G.A.W., WRIGHT, P. (1995). ROLE OF VIRAL-INFECTIONS IN THE INCEPTION OF CHILDHOOD ASTHMA AND ALLERGIES. THORAX, 50 (6), 701. doi:10.1136/thx.50.6.701
FAKOYA, A., MATEAR, P.M., FILLEY, E., ROOK, G.A.W., STANFORD, J., GILSON, R.J.C., ...VYAKARNAM, A. (1995). TH1/TH2 OR TH0-QUESTIONABLE CYTOKINE PATTERNS IN HEALTHY HIV-INFECTED INDIVIDUALS.
Kumpel, B.M., Wang, Y., Griffiths, H.L., Hadley, A.G., Rook, G.A. (1995). The biological activity of human monoclonal IgG anti-D is reduced by beta-galactosidase treatment.. Human Antibodies, 6 (3), 82-88. doi:10.3233/HAB-1995-6301
GRANGE, J.M., STANFORD, J.L., ROOK, G.A.W. (1995). TUBERCULOSIS AND CANCER - PARALLELS IN HOST RESPONSES AND THERAPEUTIC APPROACHES. LANCET, 345 (8961), 1350-1352. doi:10.1016/S0140-6736(95)92542-2
Costello, A.M., Rook, G. (1995). Tuberculosis in children.. Current opinion in pediatrics, 7 (1), 6-12. doi:10.1097/00008480-199502000-00003

1994

Rook, G.A., Onyebujoh, P., Wilkins, E., Ly, H.M., al Attiyah, R., Bahr, G., ...Stanford, J.L. (1994). A longitudinal study of per cent agalactosyl IgG in tuberculosis patients receiving chemotherapy, with or without immunotherapy.. IMMUNOLOGY, 81 (1), 149-154.
Tun, R.Y., Smith, M.D., Lo, S.S., Rook, G.A., Lydyard, P., Leslie, R.D. (1994). Antibodies to heat shock protein 65 kD in type 1 diabetes mellitus.. DIABETIC MEDICINE, 11 (1), 66-70. doi:10.1111/j.1464-5491.1994.tb00232.x
BOTTASSO, O.A., INGLEDEW, N., KENI, M., MORINI, J., PIVIDORI, J.F., ROOK, G.A.W., STANFORD, J.L. (1994). CELLULAR IMMUNE-RESPONSE TO COMMON MYCOBACTERIAL ANTIGENS IN SUBJECTS SEROPOSITIVE FOR TRYPANOSOMA-CRUZI. LANCET, 344 (8936), 1540-1541. doi:10.1016/S0140-6736(94)90351-4
EDELSTEN, C., GRAHAM, E., CHANG, Y., ROOK, G., STANFORD, J. (1994). CHANGES IN IMMUNOGLOBULIN GLYCOSYLATION ACCOMPANY ACTIVE DISEASE IN IDIOPATHIC UVEORETINITIS. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 35 (4), 2093.
van Zeben, D., Rook, G.A., Hazes, J.M., Zwinderman, A.H., Zhang, Y., Ghelani, S., ...Breedveld, F.C. (1994). Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study.. BRITISH JOURNAL OF RHEUMATOLOGY, 33 (1), 36-43.
Kumpel, B.M., Rademacher, T.W., Rook, G.A., Williams, P.J., Wilson, I.B. (1994). Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.. Human antibodies and hybridomas, 5 (3-4), 143-151.
PILKINGTON, C., ROOK, G., ISENBERG, D.A. (1994). GLYCOSYLATION OF IMMUNOGLOBULINS - PROSPECTS FOR DIAGNOSIS AND THERAPY IN RHEUMATOLOGY. CLINICAL IMMUNOTHERAPEUTICS, 1 (3), 169-172. doi:10.1007/BF03258502
Rook, G.A., Hernandez-Pando, R., Lightman, S.L. (1994). Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance.. IMMUNOLOGY TODAY, 15 (7), 301-303. doi:10.1016/0167-5699(94)90075-2
Filley, E., Thole, J.E., Rook, G.A., Nagai, S., Waters, M., Drijfhout, J.W., ...Abou-Zeid, C. (1994). Identification of an antigenic domain on Mycobacterium leprae protein antigen 85B, which is specifically recognized by antibodies from patients with leprosy.. JOURNAL OF INFECTIOUS DISEASES, 169 (1), 162-169. doi:10.1093/infdis/169.1.162
Bodman, K.B., Hutchings, P.R., Jeddi, P.A., Delves, P.J., Rook, G.A.W., Sumar, N., ...Lydyard, P.M. (1994). IgG glycosylation in autoimmune-prone strains of mice.. Clinical and Experimental Immunology, 95 103-107.
ROOK, G.A.W., ONYEBUJOH, P., STANFORD, J.L. (1994). IMMUNOENDOCRINOLOGICAL HYPOTHESIS OF HIV-INFECTION. LANCET, 344 (8923), 681. doi:10.1016/S0140-6736(94)92113-X
STANFORD, J.L., STANFORD, C.A., ROOK, G.A.W., GRANGE, J.M. (1994). IMMUNOTHERAPY FOR TUBERCULOSIS - INVESTIGATIVE AND PRACTICAL ASPECTS. CLINICAL IMMUNOTHERAPEUTICS, 1 (6), 430-440. doi:10.1007/BF03259035
STANFORD, J.L., ROOK, G.A.W., HOLTON, J., JENKINS, P.A., GRANGE, J.M. (1994). INFLAMMATORY BOWEL-DISEASE. LANCET, 343 (8909), 1359-1360. doi:10.1016/S0140-6736(94)92493-7
Rook, G.A. (1994). Macrophages and Mycobacterium tuberculosis: the key to pathogenesis.. Immunology series, 60 249-261.
Hernández-Pando, R., Reyes, P., Espitia, C., Wang, Y., Rook, G., Mancilla, R. (1994). Raised agalactosyl IgG and antimycobacterial humoral immunity in Takayasu's arteritis.. JOURNAL OF RHEUMATOLOGY, 21 (10), 1870-1876.
Smith, M.D., Lamour, A., Boylston, A., Lancaster, F.C., Pennec, Y.L., van Agthoven, A., ...Youinou, P.Y. (1994). Selective expression of V beta families by T cells in the blood and salivary gland infiltrate of patients with primary Sjögren's syndrome.. JOURNAL OF RHEUMATOLOGY, 21 (10), 1832-1837.
Fidler, H.M., Thurrell, W., Johnson, N.M., Rook, G.A., McFadden, J.J. (1994). Specific detection of Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn's disease.. GUT, 35 (4), 506-510. doi:10.1136/gut.35.4.506
Rook, G.A., Hernandez-Pando, R. (1994). T cell helper types and endocrines in the regulation of tissue-damaging mechanisms in tuberculosis.. IMMUNOBIOLOGY, 191 (4-5), 478-492. doi:10.1016/S0171-2985(11)80454-7
HERNANDEZPANDO, R., ROOK, G.A.W. (1994). THE ROLE OF TNF-ALPHA IN T-CELL-MEDIATED INFLAMMATION DEPENDS ON THE TH1/TH2 CYTOKINE BALANCE. IMMUNOLOGY, 82 (4), 591-595.
GRANGE, J.M., STANFORD, J.L., ROOK, G., ONYEBUJOH, P., BRETSCHER, P.A. (1994). TUBERCULOSIS AND HIV - LIGHT AFTER DARKNESS. THORAX, 49 (6), 537-539. doi:10.1136/thx.49.6.537

1993

Rook, G.A., Lydyard, P.M., Stanford, J.L. (1993). A reappraisal of the evidence that rheumatoid arthritis and several other idiopathic diseases are slow bacterial infections.. ANNALS OF THE RHEUMATIC DISEASES, 52 S30-S38. doi:10.1136/ard.52.Suppl_1.S30
STANFORD, J.L., STANFORD, C.A., ROOK, G.A.W., CARSWELL, J.W., GRANGE, J.M., POZNIAK, A. (1993). CHEMOPROPHYLAXIS FOR TUBERCULOSIS. RESPIRATORY MEDICINE, 87 (5), 398-399. doi:10.1016/0954-6111(93)90057-7
ROOK, G.A.W., PILKINGTON, C., TAYLOR, P., LEFVERT, A.K. (1993). CIRCUMSTANTIAL EVIDENCE THAT AGALACTOSYL IGG HAS A PATHOGENETIC ROLE IN AUTOANTIBODY-MEDIATED DISEASE. JOURNAL OF CELLULAR BIOCHEMISTRY, 151.
Pilkington, C., Costello, A.M., Rook, G.A., Stanford, J.L. (1993). Development of IgG responses to mycobacterial antigens.. ARCHIVES OF DISEASE IN CHILDHOOD, 69 (6), 644-649. doi:10.1136/adc.69.6.644
FIDLER, H., ROOK, G., JOHNSON, N.M., OCONNOR, C. (1993). ETIOLOGY OF TUBERCULIDS. LANCET, 341 (8844), 565-566. doi:10.1016/0140-6736(93)90335-E
FIDLER, H., ROOK, G., JOHNSON, N.M., MCFADDEN, J.J. (1993). MYCOBACTERIA AND SARCOIDOSIS - REPLY. BRITISH MEDICAL JOURNAL, 306 (6887), 1270-1271. doi:10.1136/bmj.306.6887.1270-c
Fidler, H., Rook, G., Johnson, N.M., McFadden, J. (1993). Mycobacteria and sarcoidosis: Authors' reply. BMJ (Clinical research ed.), 306 (6887), 1270-1271. doi:10.1136/bmj.306.6887.1270-c
FIDLER, H.M., ROOK, G.A., JOHNSON, N.M., MCFADDEN, J. (1993). MYCOBACTERIUM-TUBERCULOSIS DNA IN TISSUE AFFECTED BY SARCOIDOSIS. BRITISH MEDICAL JOURNAL, 306 (6877), 546-549. doi:10.1136/bmj.306.6877.546
ROOK, G.A.W. (1993). NEW MEANINGS FOR AN OLD WORD - ADJUVANTICITY, CYTOKINES AND T-CELLS. IMMUNOLOGY TODAY, 14 (2), 95-96. doi:10.1016/0167-5699(93)90072-S
STANFORD, J.L., ONYEBUJOH, P.C., ROOK, G.A.W., GRANGE, J.M., POZNIAK, A. (1993). OLD PLAGUE, NEW PLAGUE, AND A TREATMENT FOR BOTH. AIDS, 7 (9), 1275-1277.
McCulloch, J., Lydyard, P.M., Rook, G.A. (1993). Rheumatoid arthritis: how well do the theories fit the evidence?. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 92 (1), 1-6.
Fidler, H., Rook, G.A.W., Johnson, N.M., McFadden, J.J. (1993). Search for Mycobacterial DNA dn Granulomatous Tissues from Patients with Sarcoidosis Using the Polymerase Chain Reaction. American Review of Respiratory Disease, 147 (3), 777. doi:10.1164/ajrccm/147.3.777
Fidler, H., Rook, G.A., Johnson, N.M., McFadden, J.J. (1993). Search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction.. AMERICAN REVIEW OF RESPIRATORY DISEASE, 147 (3), 777. doi:10.1164/ajrccm/147.3.777
LYDYARD, P.M., SMITH, M.D., LAMOUR, A., BOYLSTON, A., LANCASTER, F.C., PONNEC, Y.L., ...YOUINOU, P.Y. (1993). SELECTIVE EXPRESSION OF V-BETA FAMILIES BY T-CELLS IN PRIMARY SJOGRENS-SYNDROME. ARTHRITIS AND RHEUMATISM, 36 (9), S197.
FIDLER, H., ROOK, G.A.W., JOHNSON, N.M., MCFADDEN, J.J. (1993). SPECIFICITY OF PRIMERS BASED ON IS6110 TO MYCOBACTERIUM-TUBERCULOSIS COMPLEX DNA. TUBERCLE AND LUNG DISEASE, 74 (6), 414-415. doi:10.1016/0962-8479(93)90095-F
ROOK, G.A.W., ONYEBUJOH, P., STANFORD, J.L. (1993). TH1/TH2 SWITCHING AND LOSS OF CD4+ T-CELLS IN CHRONIC INFECTIONS - AN IMMUNOENDOCRINOLOGICAL HYPOTHESIS NOT EXCLUSIVE TO HIV. IMMUNOLOGY TODAY, 14 (11), 568-569. doi:10.1016/0167-5699(93)90190-V
Lambert, C., Brealey, R., Steele, J., Rook, G.A. (1993). The interaction of Tamm-Horsfall protein with the extracellular matrix.. IMMUNOLOGY, 79 (2), 203-210.

1992

al Attiyah, R., Rosen, H., Rook, G.A. (1992). A model for the investigation of factors influencing haemorrhagic necrosis mediated by tumour necrosis factor in tissue sites primed with mycobacterial antigen preparations.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 88 (3), 537-542.
Thompson, S.J., Hitsumoto, Y., Zhang, Y.W., Rook, G.A., Elson, C.J. (1992). Agalactosyl IgG in pristane-induced arthritis. Pregnancy affects the incidence and severity of arthritis and the glycosylation status of IgG.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 89 (3), 434-438.
Rook, G.A., Vyakarnam, A. (1992). Cytokines, lymphokines, mycobacteria and AIDS.. RESEARCH IN MICROBIOLOGY, 143 (4), 406-410. doi:10.1016/0923-2508(92)90054-R
Costello, A.M., Kumar, A., Narayan, V., Akbar, M.S., Ahmed, S., Abou-Zeid, C., ...Moreno, C. (1992). Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis?. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 86 (6), 686-692.
Rook, G., McCulloch, J. (1992). HLA-DR4, mycobacteria, heat-shock proteins, and rheumatoid arthritis.. ARTHRITIS AND RHEUMATISM, 35 (12), 1409-1412. doi:10.1002/art.1780351202
Mattsson, R., Mattsson, A., Hansson, I., Holmdahl, R., Rook, G.A., Whyte, A. (1992). Increased levels of prolactin during, but not after, the immunisation with rat collagen II enhances the course of arthritis in DBA/1 mice.. AUTOIMMUNITY, 11 (3), 163-170. doi:10.3109/08916939209035151
GOUGEON, M.L., MONTAGNIER, L., COLLINS, F.M., COKER, R.J., WEBER, J.N., BROWN, I.N., ...YAJKO, D.M. (1992). MYCOBACTERIA AND AIDS - EPIDEMIOLOGIC AND GENETIC-MARKERS, VIRULENCE FACTORS AND INTERACTIONS WITH THE IMMUNE-SYSTEM - DISCUSSION. RESEARCH IN MICROBIOLOGY, 143 (4), 430-436. doi:10.1016/0923-2508(92)90058-V
Hitsumoto, Y., Thompson, S.J., Zhang, Y.W., Rook, G.A., Elson, C.J. (1992). Relationship between interleukin 6, agalactosyl IgG and pristane-induced arthritis.. AUTOIMMUNITY, 11 (4), 247-254. doi:10.3109/08916939209035162
OCONNOR, C.M., ROOK, G., FITZGERALD, M.X. (1992). SERUM AGALACTOSYL IGG LEVELS IN SARCOIDOSIS.
Rook, G.A., Stanford, J.L. (1992). Slow bacterial infections or autoimmunity?. IMMUNOLOGY TODAY, 13 (5), 160-164. doi:10.1016/0167-5699(92)90119-R
Sharif, M., Worrall, J.G., Singh, B., Gupta, R.S., Lydyard, P.M., Lambert, C., ...Rook, G.A. (1992). The development of monoclonal antibodies to the human mitochondrial 60-kd heat-shock protein, and their use in studying the expression of the protein in rheumatoid arthritis.. ARTHRITIS AND RHEUMATISM, 35 (12), 1427-1433. doi:10.1002/art.1780351205
Filley, E.A., Bull, H.A., Dowd, P.M., Rook, G.A. (1992). The effect of Mycobacterium tuberculosis on the susceptibility of human cells to the stimulatory and toxic effects of tumour necrosis factor.. IMMUNOLOGY, 77 (4), 505-509.
al Attiyah, R., Moreno, C., Rook, G.A. (1992). TNF alpha-mediated tissue damage in mouse footpads primed with mycobacterial preparations.. RESEARCH IN IMMUNOLOGY, 143 (6), 601-610.
Foley, N.M., Millar, A.B., Meager, A., Johnson, N.M., Rook, G.A. (1992). Tumour necrosis factor production by alveolar macrophages in pulmonary sarcoidosis and tuberculosis.. Sarcoidosis, 9 (1), 29-34.
Rook, G. (1992). Tumours and Coley's toxins.. NATURE, 357 (6379), 545. doi:10.1038/357545a0

1991

Rook, G.A., Steele, J., Brealey, R., Whyte, A., Isenberg, D., Sumar, N., ...Roitt, I.M. (1991). Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy.. JOURNAL OF AUTOIMMUNITY, 4 (5), 779-794. doi:10.1016/0896-8411(91)90173-A
ROOK, G.A.W., ALATTIYAH, R. (1991). CYTOKINES AND THE KOCH PHENOMENON - REVIEW. TUBERCLE, 72 (1), 13-20. doi:10.1016/0041-3879(91)90019-O
Rook, G.A., al Attiyah, R. (1991). Cytokines and the Koch phenomenon.. Tubercle, 72 (1), 13-20. doi:10.1016/0041-3879(91)90019-o
Filley, E.A., Rook, G.A. (1991). Effect of mycobacteria on sensitivity to the cytotoxic effects of tumor necrosis factor.. INFECTION AND IMMUNITY, 59 (8), 2567-2572. doi:10.1128/IAI.59.8.2567-2572.1991
Rook, G.A., Taverne, J., Playfair, J.H. (1991). Evaluation of TNF as antiviral, antibacterial and antiparasitic agent.. BIOTHERAPY, 3 (2), 167-175. doi:10.1007/BF02172089
Abou-Zeid, C., Garbe, T., Lathigra, R., Wiker, H.G., Harboe, M., Rook, G.A., Young, D.B. (1991). Genetic and immunological analysis of Mycobacterium tuberculosis fibronectin-binding proteins.. INFECTION AND IMMUNITY, 59 (8), 2712-2718. doi:10.1128/IAI.59.8.2712-2718.1991
Lydyard, P.M., Rook, G.A., Tsoulfa, G., Sharif, M., Smith, M. (1991). Is there a role for mycobacteria in the etiopathogenesis of rheumatoid arthritis?. IMMUNOLOGICAL REVIEWS, 121 137-154. doi:10.1111/j.1600-065X.1991.tb00826.x
Mattsson, R., Mattsson, A., Holmdahl, R., Whyte, A., Rook, G.A. (1991). Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 85 (1), 41-47.
Rook, G.A. (1991). Mobilising the appropriate T-cell subset: the immune response as taxonomist?. TUBERCLE, 72 (4), 253-254. doi:10.1016/0041-3879(91)90049-X
Thompson, S.J., Butcher, P.D., Patel, V.K., Rook, G.A., Stanford, J., van der Zee, R., Elson, C.J. (1991). Modulation of pristane-induced arthritis by mycobacterial antigens.. AUTOIMMUNITY, 11 (1), 35-43. doi:10.3109/08916939108994706
ONYEBUJOH, P., ROOK, G. (1991). MYCOBACTERIUM-VACCAE IMMUNOTHERAPY. LANCET, 338 (8781), 1534.
Rook, G.A., al Attiyah, R., Filley, E. (1991). New insights into the immunopathology of tuberculosis.. PATHOBIOLOGY, 59 (3), 148-152. doi:10.1159/000163633
Millar, A.B., Miller, R.F., Foley, N.M., Meager, A., Semple, S.J., Rook, G.A. (1991). Production of tumor necrosis factor-alpha by blood and lung mononuclear phagocytes from patients with human immunodeficiency virus-related lung disease.. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 5 (2), 144-148. doi:10.1165/ajrcmb/5.2.144
Rook, G., Thompson, S., Buckley, M., Elson, C., Brealey, R., Lambert, C., ...Rademacher, T. (1991). The role of oil and agalactosyl IgG in the induction of arthritis in rodent models.. EUROPEAN JOURNAL OF IMMUNOLOGY, 21 (4), 1027-1032. doi:10.1002/eji.1830210425

1990

Dubé, R., Rook, G.A., Steele, J., Brealey, R., Dwek, R., Rademacher, T., Lennard-Jones, J. (1990). Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.. GUT, 31 (4), 431-434. doi:10.1136/gut.31.4.431
BAHR, G.M., YOUSOF, A.M., MAJEED, H.A.M., BEHBEHANI, K., LUBANI, M., PAREKH, R.B., ...MEHLERT, A. (1990). AGALACTOSYL IGG, ANTIBODIES TO HEAT-SHOCK PROTEINS, AND ACUTE RHEUMATIC-FEVER. ANNALS OF THE RHEUMATIC DISEASES, 49 (6), 383-386. doi:10.1136/ard.49.6.383
Foley, N., Lambert, C., McNicol, M., Johnson, N., Rook, G.A. (1990). An inhibitor of the toxicity of tumour necrosis factor in the serum of patients with sarcoidosis, tuberculosis and Crohn's disease.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 80 (3), 395-399.
Bahr, G.M., Stanford, J.L., Chugh, T.D., Shaaban, M.A., Gabriel, M., al-Shimali, B., ...Shahin, A. (1990). An investigation of patients with pulmonary tuberculosis in Kuwait in preparation for studies of immunotherapy with Mycobacterium vaccae.. TUBERCLE, 71 (2), 77-86. doi:10.1016/0041-3879(90)90001-O
Sumar, N., Bodman, K.B., Rademacher, T.W., Dwek, R.A., Williams, P., Parekh, R.B., ...Hay, F.C. (1990). Analysis of glycosylation changes in IgG using lectins.. JOURNAL OF IMMUNOLOGICAL METHODS, 131 (1), 127-136. doi:10.1016/0022-1759(90)90242-N
Thompson, S.J., Rook, G.A., Brealey, R.J., Van der Zee, R., Elson, C.J. (1990). Autoimmune reactions to heat-shock proteins in pristane-induced arthritis.. EUROPEAN JOURNAL OF IMMUNOLOGY, 20 (11), 2479-2484. doi:10.1002/eji.1830201118
Taverne, J., Bate, C.A., Sarkar, D.A., Meager, A., Rook, G.A., Playfair, J.H. (1990). Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum.. PARASITE IMMUNOLOGY, 12 (1), 33-43. doi:10.1111/j.1365-3024.1990.tb00934.x
Lydyard, P.M., Tsoulfa, G., Sharif, M., Bröker, B., Smith, M., Rook, G.A. (1990). Immunity to heat shock proteins in rheumatoid arthritis.. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 8 69-74.
Stanford, J.L., Bahr, G.M., Rook, G.A., Shaaban, M.A., Chugh, T.D., Gabriel, M., ...Shahin, A. (1990). Immunotherapy with Mycobacterium vaccae as an adjunct to chemotherapy in the treatment of pulmonary tuberculosis.. TUBERCLE, 71 (2), 87-93. doi:10.1016/0041-3879(90)90002-P
BAHR, G.M., SHAABAN, M.A., GABRIEL, M., ALSHIMALI, B., SIDDIQUI, Z., CHUGH, T.D., ...CHEDID, L. (1990). IMPROVED IMMUNOTHERAPY FOR PULMONARY TUBERCULOSIS WITH MYCOBACTERIUM-VACCAE. TUBERCLE, 71 (4), 259-266. doi:10.1016/0041-3879(90)90038-A
ROOK, G.A.W. (1990). KILLING INTRACELLULAR MYCOBACTERIA - DOGMAS AND REALITIES. RESEARCH IN MICROBIOLOGY, 141 (2), 267-268.
Rook, G., Lydyard, P., Stanford, J. (1990). Mycobacteria and rheumatoid arthritis.. ARTHRITIS AND RHEUMATISM, 33 (3), 431-435. doi:10.1002/art.1780330319
Rook, G.A. (1990). Mycobacteria, cytokines and antibiotics.. PATHOLOGIE BIOLOGIE, 38 (4), 276-280.
Stanford, J.L., Rook, G.A., Bahr, G.M., Dowlati, Y., Ganapati, R., Ghazi Saidi, K., ...Minh Ly, H. (1990). Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis.. VACCINE, 8 (6), 525-530. doi:10.1016/0264-410X(90)90002-4
Sharif, M., Rook, G., Wilkinson, L.S., Worrall, J.G., Edwards, J.C. (1990). Terminal N-acetylglucosamine in chronic synovitis.. BRITISH JOURNAL OF RHEUMATOLOGY, 29 (1), 25-31.
ROOK, G.A.W. (1990). THE IMMUNOPATHOLOGY OF TUBERCULOSIS. EOS-RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA, 10 (2), 64-68.
Rook, G.A. (1990). The role of activated macrophages in protection and immunopathology in tuberculosis.. RESEARCH IN MICROBIOLOGY, 141 (2), 253-256. doi:10.1016/0923-2508(90)90040-W
ROOK, G.A.W., TAVERNE, J., MORENO, C. (1990). THE ROLE OF TUMOR-NECROSIS-FACTOR IN THE PATHOGENESIS OF TUBERCULOSIS AND LEPROSY, AND THE RELATIONSHIP BETWEEN TISSUE-DAMAGING PATHOLOGY AND PRODUCTION OF AGALACTOSYL IGG.
Roitt, I.M., Dwek, R.A., Parekh, R.B., Rademacher, T.W., Warren, C., Alavi, A., ...Colaco, B. (1990). The significance of changes in IgG carbohydrate in rheumatoid arthritis and tuberculosis.. Advances in Host Defence Mechanisms, 7 77-91.
MILLAR, A.B., MILLER, R.F., FOLEY, N.M., ROOK, G.A.W., SEMPLE, S.J.G. (1990). TUMOR-NECROSIS-FACTOR (TNF ALPHA) PRODUCTION BY PERIPHERAL-BLOOD MONOCYTES AND ALVEOLAR MACROPHAGES FROM PATIENTS WITH HIV-RELATED LUNG-DISEASE. CLINICAL SCIENCE, 78 (4), P17.
Rook, G.A., Foley, N.M., Meager, A. (1990). What mediates the immunopathological component of the immune response to Mycobacterium tuberculosis? Can it be switched off?. Bulletin of the International Union against Tuberculosis and Lung Disease, 65 (2-3), 23-26.

1989

Parekh, R., Isenberg, D., Rook, G., Roitt, I., Dwek, R., Rademacher, T. (1989). A comparative analysis of disease-associated changes in the galactosylation of serum IgG.. JOURNAL OF AUTOIMMUNITY, 2 (2), 101-114. doi:10.1016/0896-8411(89)90148-0
Filley, E., Andreoli, A., Steele, J., Waters, M., Wagner, D., Nelson, D., ...Rook, G.A. (1989). A transient rise in agalactosyl IgG correlating with free interleukin 2 receptors, during episodes of erythema nodosum leprosum.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 76 (3), 343-347.
Bahr, G.M., Eales, L.J., Nye, K.E., Majeed, H.A., Yousof, A.M., Behbehani, K., Rook, G.A. (1989). An association between Gc (vitamin D-binding protein) alleles and susceptibility to rheumatic fever.. IMMUNOLOGY, 67 (1), 126-128.
Barnes, P.F., Mehra, V., Hirschfield, G.R., Fong, S.J., Abou-Zeid, C., Rook, G.A., ...Modlin, R.L. (1989). Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis.. JOURNAL OF IMMUNOLOGY, 143 (8), 2656-2662.
Axford, J.S., Bodman, K., Hay, F.C., Isenberg, D.A., Lydyard, P.M., Mackenzie, L., ...Dwek, R.A. (1989). Comment on the article by Tomana et al.. Arthritis and rheumatism, 32 (2), 235-236. doi:10.1002/anr.1780320223
Tsoulfa, G., Rook, G.A., Bahr, G.M., Sattar, M.A., Behbehani, K., Young, D.B., ...Isenberg, D.A. (1989). Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritis.. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 30 (5), 519-527. doi:10.1111/j.1365-3083.1989.tb02459.x
BAHR, G.M., SATTAR, M.A., STANFORD, J.L., SHAABAN, M.A., ALSHIMALI, B., SIDDIQUI, Z., ...CHUGH, T.D. (1989). HLA-DR AND TUBERCULIN TESTS IN RHEUMATOID-ARTHRITIS AND TUBERCULOSIS. ANNALS OF THE RHEUMATIC DISEASES, 48 (1), 63-68. doi:10.1136/ard.48.1.63
Moreno, C., Taverne, J., Mehlert, A., Bate, C.A., Brealey, R.J., Meager, A., ...Playfair, J.H. (1989). Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 76 (2), 240-245.
Sharif, M., Wilkinson, L.S., Edwards, J., Rook, G.A. (1989). Membrane N-acetylglucosamine: expression by cells in rheumatoid synovial fluid, and by pre-cultured monocytes.. BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY, 70 (5), 567-577.
Tsoulfa, G., Rook, G.A., Van-Embden, J.D., Young, D.B., Mehlert, A., Isenberg, D.A., ...Lydyard, P.M. (1989). Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis.. ANNALS OF THE RHEUMATIC DISEASES, 48 (2), 118-123. doi:10.1136/ard.48.2.118
Leveton, C., Barnass, S., Champion, B., Lucas, S., De Souza, B., Nicol, M., ...Rook, G. (1989). T-cell-mediated protection of mice against virulent Mycobacterium tuberculosis.. INFECTION AND IMMUNITY, 57 (2), 390-395. doi:10.1128/IAI.57.2.390-395.1989
Rook, G.A., Attiyah, R.A., Foley, N. (1989). The role of cytokines in the immunopathology of tuberculosis, and the regulation of agalactosyl IgG.. LYMPHOKINE RESEARCH, 8 (3), 323-328.
ROOK, G.A.W. (1989). THE ROLE OF VITAMIN-D IN TUBERCULOSIS - REPLY. AMERICAN REVIEW OF RESPIRATORY DISEASE, 139 (6), 1571. doi:10.1164/ajrccm/139.6.1571a
Filley, E., Abou-Zeid, C., Waters, M., Rook, G. (1989). The use of antigen-bearing nitrocellulose particles derived from Western blots to study proliferative responses to 27 antigenic fractions from Mycobacterium leprae in patients and controls.. IMMUNOLOGY, 67 (1), 75-80.
Millar, A.B., Foley, N.M., Singer, M., Johnson, N.M., Meager, A., Rook, G.A. (1989). Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome.. LANCET, 2 (8665), 712-714. doi:10.1016/S0140-6736(89)90772-1
Ghazi Saidi, K., Stanford, J.L., Stanford, C.A., Dowlati, Y., Farshchi, Y., Rook, G.A., Rees, R.J. (1989). Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.. INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 57 (1), 45-53.

1988

Rook, G.A., Steele, J., Rademacher, T. (1988). A monoclonal antibody raised by immunising mice with group A streptococci binds to agalactosyl IgG from rheumatoid arthritis.. ANNALS OF THE RHEUMATIC DISEASES, 47 (3), 247-250. doi:10.1136/ard.47.3.247
Bahr, G.M., Rook, G.A., al-Saffar, M., Van Embden, J., Stanford, J.L., Behbehani, K. (1988). Antibody levels to mycobacteria in relation to HLA type: evidence for non-HLA-linked high levels of antibody to the 65 kD heat shock protein of M. bovis in rheumatoid arthritis.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 74 (2), 211-215.
Ratliff, T.L., McGarr, J.A., Abou-Zeid, C., Rook, G.A., Stanford, J.L., Aslanzadeh, J., Brown, E.J. (1988). Attachment of mycobacteria to fibronectin-coated surfaces.. JOURNAL OF GENERAL MICROBIOLOGY, 134 1307-1313.
Abou-Zeid, C., Ratliff, T.L., Wiker, H.G., Harboe, M., Bennedsen, J., Rook, G.A. (1988). Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG.. INFECTION AND IMMUNITY, 56 (12), 3046-3051. doi:10.1128/IAI.56.12.3046-3051.1988
SHARIF, M., WILKINSON, I., ROOK, G., EDWARDS, J. (1988). EXPOSURE OF TERMINAL N-ACETYLGLUCOSAMINE IN CHRONIC SYNOVITIS. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 28 (4), 507.
AXFORD, J.S., HAY, F.C., MACKENZIE, L., ISENBERG, D.A., LYDYARD, P.M., ROITT, I.M., ...DWEK, R.A. (1988). GALACTOSE RESIDUES IN CHRONIC INFLAMMATORY DISEASE - REPLY. LANCET, 1 (8582), 418.
Isenberg, D.A., Axford, J.S., Lydyard, P.M., Hay, F.C., Rook, G.W., Roitt, I.M., ...Rademacher, T.W. (1988). GALACTOSYLATION OF IgG ASSOCIATED OLIGOSACCHARIDES. The Lancet, 332 (8605), 288. doi:10.1016/s0140-6736(88)92589-5
ISENBERG, D.A., LYDYARD, P.M., AXFORD, J.S., HAY, F.C., ROOK, G.W., ROITT, I.M., ...RADEMACHER, T.W. (1988). GALACTOSYLATION OF IGG ASSOCIATED OLIGOSACCHARIDES. LANCET, 2 (8605), 288.
ROOK, G.A.W., BAHR, G.M., STANFORD, J.L., BEHBEHANI, K. (1988). HLA AND ANTIBODY TO MYCOBACTERIA IN RHEUMATOID-ARTHRITIS - STRONG ISOTYPE SPECIFIC CORRELATION WITH DR2 AND DR7. DISEASE MARKERS, 6 (1), 63-64.
STANFORD, J.L., ROOK, G.A.W., BAHR, G.M., SATTAR, I., BEHBEHANI, K. (1988). HLA-DR AND TUBERCULIN TESTS IN RHEUMATOID-ARTHRITIS - EVIDENCE SUPPORTING A RELATIONSHIP BETWEEN MYCOBACTERIA AND THE ETIOLOGY OF THE DISEASE. DISEASE MARKERS, 6 (1), 63.
Bahr, G.M., Rook, G.A., Shahin, A., Stanford, J.L., Sattar, M.I., Behbehani, K. (1988). HLA-DR-associated isotype-specific regulation of antibody levels to mycobacteria in rheumatoid arthritis.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 72 (1), 26-31.
Roberts, D., Katz, D.R., Mukherjee, S., Rook, G.A. (1988). Induction of delayed-type hypersensitivity responses to PPD: dendritic cells in synergy with 5-hydroxytryptamine can substitute for macrophages.. IMMUNOLOGY, 63 (4), 697-700.
ROOK, G.A.W. (1988). RHEUMATOID-ARTHRITIS, MYCOBACTERIAL ANTIGENS AND AGALACTOSYL IGG. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 28 (4), 487-493. doi:10.1111/j.1365-3083.1988.tb01480.x
Rook, G.A. (1988). Role of activated macrophages in the immunopathology of tuberculosis.. BRITISH MEDICAL BULLETIN, 44 (3), 611-623. doi:10.1093/oxfordjournals.bmb.a072271
Chao, L.P., Steele, J., Rodrigues, C., Lennard-Jones, J., Stanford, J.L., Spiliadis, C., Rook, G.A. (1988). Specificity of antibodies secreted by hybridomas generated from activated B cells in the mesenteric lymph nodes of patients with inflammatory bowel disease.. GUT, 29 (1), 35-40. doi:10.1136/gut.29.1.35
ROITT, I.M., DWEK, R.A., PAREKH, R.B., RADEMACHER, T.W., ALAVI, A., AXFORD, J.S., ...HAY, F.C. (1988). THE ROLE OF ANTIGEN IN AUTOIMMUNE RESPONSES WITH SPECIAL REFERENCE TO CHANGES IN CARBOHYDRATE STRUCTURE OF IGG IN RHEUMATOID-ARTHRITIS. JOURNAL OF AUTOIMMUNITY, 1 (6), 499-506. doi:10.1016/0896-8411(88)90043-1
Rademacher, T.W., Parekh, R.B., Dwek, R.A., Isenberg, D., Rook, G., Axford, J.S., Roitt, I. (1988). The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis.. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 10 (2-3), 231-249. doi:10.1007/BF01857227
Rook, G.A. (1988). The role of vitamin D in tuberculosis.. AMERICAN REVIEW OF RESPIRATORY DISEASE, 138 (4), 768-770. doi:10.1164/ajrccm/138.4.768
Abou-Zeid, C., Smith, I., Grange, J.M., Ratliff, T.L., Steele, J., Rook, G.A. (1988). The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies.. JOURNAL OF GENERAL MICROBIOLOGY, 134 531-538.
FOLEY, N.M., MILLAR, A.B., ROOK, G.A.W., JOHNSON, N. (1988). TUMOR NECROSIS FACTOR RELEASE BY PULMONARY ALVEOLAR MACROPHAGES. THORAX, 43 (3), P246-P247.

1987

Rook, G.A., Steele, J., Ainsworth, M., Leveton, C. (1987). A direct effect of glucocorticoid hormones on the ability of human and murine macrophages to control the growth of M. tuberculosis.. EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 71 (4), 286-291.
Abou-Zeid, C., Filley, E., Steele, J., Rook, G.A. (1987). A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen-bearing particles.. JOURNAL OF IMMUNOLOGICAL METHODS, 98 (1), 5-10. doi:10.1016/0022-1759(87)90429-7
Abou-Zeid, C., Harboe, M., Rook, G.A. (1987). Characterization of the secreted antigens of Mycobacterium bovis BCG: comparison of the 46-kilodalton dimeric protein with proteins MPB64 and MPB70.. INFECTION AND IMMUNITY, 55 (12), 3213-3214. doi:10.1128/IAI.55.12.3213-3214.1987
Abou-Zeid, C., Rook, G.A., Minnikin, D.E., Parlett, J.H., Osborn, T.W., Grange, J.M. (1987). Effect of the method of preparation of bacille Calmette-Guérin (BCG) vaccine on the properties of four daughter strains.. JOURNAL OF APPLIED BACTERIOLOGY, 63 (5), 449-453.
Poulter, L.W., Rook, G.A., Steele, J., Condez, A. (1987). Influence of 1,25-(OH)2 vitamin D3 and gamma interferon on the phenotype of human peripheral blood monocyte-derived macrophages.. INFECTION AND IMMUNITY, 55 (9), 2017-2020. doi:10.1128/IAI.55.9.2017-2020.1987
Rook, G.A., Steele, J. (1987). Macrophage regulation of vitamin D3 metabolites.. NATURE, 326 (6108), 21-22. doi:10.1038/326021b0
Rook, G.A. (1987). Progress in the immunology of the mycobacterioses.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 69 (1), 1-9.
Mahmood, K.H., Stanford, J.L., Rook, G.A., Stuart, F.A., Pritchard, D.G., Brewer, J.I. (1987). The immune response in two populations of wild badgers naturally infected with bovine tubercle bacilli.. TUBERCLE, 68 (2), 119-125. doi:10.1016/0041-3879(87)90027-4
Mahmood, K.H., Rook, G.A., Stanford, J.L., Stuart, F.A., Pritchard, D.G. (1987). The immunological consequences of challenge with bovine tubercle bacilli in badgers (Meles meles).. Epidemiol Infect, 98 (2), 155-163. doi:10.1017/S0950268800061860
Rook, G.A., Taverne, J., Leveton, C., Steele, J. (1987). The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis.. IMMUNOLOGY, 62 (2), 229-234.
Bahr, G.M., Chugh, T.D., Behbehani, K., Shaaban, M.A., Abdul-Aty, M., Al Shimali, B., ...Stanford, J.L. (1987). Unexpected findings amongst the skin test responses to mycobacteria of BCG vaccinated Kuwaiti school children.. TUBERCLE, 68 (2), 105-112. doi:10.1016/0041-3879(87)90025-0

1986

Rook, G.A., Steele, J., Ainsworth, M., Champion, B.R. (1986). Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages.. IMMUNOLOGY, 59 (3), 333-338.
KATZ, D.R., MUKHERJEE, S., ROBERTS, D., ROOK, G.A.W. (1986). DIFFERING ROLE OF DENDRITIC CELLS AND MACROPHAGES IN INVIVO RESPONSES TO MYCOBACTERIAL ANTIGENS. JOURNAL OF PATHOLOGY, 149 (3), A255.
Mukherjee, S., Katz, D.R., Rook, G.A. (1986). Differing role of dendritic cells and macrophages in the induction of delayed-type hypersensitivity responses to PPD.. IMMUNOLOGY, 59 (2), 229-234.
Rook, G.A. (1986). Gamma interferon and calcitriol formation by human macrophages.. BIOESSAYS, 5 (1), 40-41. doi:10.1002/bies.950050112
Steele, J., Flint, K.C., Pozniak, A.L., Hudspith, B., Johnson, M.M., Rook, G.A. (1986). Inhibition of virulent Mycobacterium tuberculosis by murine peritoneal macrophages and human alveolar lavage cells: the effects of lymphokines and recombinant gamma interferon.. TUBERCLE, 67 (4), 289-294. doi:10.1016/0041-3879(86)90018-8
Barnass, S., Mace, J., Steele, J., Torres, P., Gervasoni, B., Ravioli, R., ...Waters, M.F. (1986). Prevalence and specificity of the enhancing effect of three types of interleukin 2 on T cell responsiveness in 97 lepromatous leprosy patients of mixed ethnic origin.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 64 (1), 41-49.
Rook, G.A., Steele, J., Barnass, S., Mace, J., Stanford, J.L. (1986). Responsiveness to live M. tuberculosis, and common antigens, of sonicate-stimulated T cell lines from normal donors.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 63 (1), 105-110.
Bahr, G.M., Stanford, J.L., Rook, G.A., Rees, R.J., Frayha, G.J., Abdelnoor, A.M. (1986). Skin sensitization to mycobacteria amongst school children prior to a study of BCG vaccination in North Lebanon.. TUBERCLE, 67 (3), 197-203. doi:10.1016/S0041-3879(86)80026-5
Abou-Zeid, C., Smith, I., Grange, J., Steele, J., Rook, G. (1986). Subdivision of daughter strains of bacille Calmette-Guérin (BCG) according to secreted protein patterns.. JOURNAL OF GENERAL MICROBIOLOGY, 132 3047-3053.
Nye, P.M., Stanford, J.L., Rook, G.A., Lawton, P., MacGregor, M., Reily, C., ...Terencio de las Aguas, J. (1986). Suppressor determinants of mycobacteria and their potential relevance to leprosy.. LEPROSY REVIEW, 57 (2), 147-157.
Bahr, G.M., Stanford, J.L., Rook, G.A., Rees, R.J., Abdelnoor, A.M., Frayha, G.J. (1986). Two potential improvements to BCG and their effect on skin test reactivity in the Lebanon.. TUBERCLE, 67 (3), 205-218. doi:10.1016/S0041-3879(86)80027-7
Rook, G. (1986). Vitamin D and tuberculosis.. TUBERCLE, 67 (2), 155-156. doi:10.1016/0041-3879(86)90011-5
Rook, G.A., Steele, J., Fraher, L., Barker, S., Karmali, R., O'Riordan, J., Stanford, J. (1986). Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes.. IMMUNOLOGY, 57 (1), 159-163.

1985

Rook, G.A., Steele, J., Umar, S., Dockrell, H.M. (1985). A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by gamma-interferon.. JOURNAL OF IMMUNOLOGICAL METHODS, 82 (1), 161-167. doi:10.1016/0022-1759(85)90235-2
Rook, G.A. (1985). Absence from sera from normal individuals or from rifampin-treated leprosy patients (THELEP trials) of antibody to rifamycin-protein or rifamycin-membrane conjugates.. INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 53 (1), 22-27.
Andreoli, A., Brett, S.J., Draper, P., Payne, S.N., Rook, G.A. (1985). Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients.. INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 53 (2), 211-217.
Rook, G.A., Champion, B.R., Steele, J., Varey, A.M., Stanford, J.L. (1985). I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 59 (2), 414-420.
ROOK, G.A.W. (1985). NON-REPELLENT BIRD DROPPINGS. NATURE, 318 (6043), 237. doi:10.1038/318237c0
Altes, C., Steele, J., Stanford, J.L., Rook, G.A. (1985). The effect of lymphokines on the ability of macrophages to protect mycobacteria from a bactericidal antibiotic.. TUBERCLE, 66 (4), 261-266. doi:10.1016/0041-3879(85)90063-7

1984

Morton, A., Nye, P., Rook, G.A., Samuel, N., Stanford, J.L. (1984). A further investigation of skin-test responsiveness and suppression in leprosy patients and healthy school children in Nepal.. LEPROSY REVIEW, 55 (3), 273-281.
ROOK, G.A.W., CHAMPION, B.R., STEELE, J., VAREY, A.M., STANFORD, J.L. (1984). I-A RESTRICTED ACTIVATION BY T-CELL LINES OF ANTI-TUBERCULOSIS ACTIVITY IN MURINE MACROPHAGES. JOURNAL OF LEUKOCYTE BIOLOGY, 36 (3), 398.

1983

Rook, G.A. (1983). [Importance of recent advances in our understanding of antimicrobial cell-mediated immunity to the International Union for the Prevention of Tuberculosis].. Bulletin of the International Union against Tuberculosis, 58 (1), 62-72.
van Eden, W., de Vries, R.R., Stanford, J.L., Rook, G.A. (1983). HLA-DR3 associated genetic control of response to multiple skin tests with new tuberculins.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 52 (2), 287-292.
ROOK, G.A.W. (1983). IMMUNITY AND HYPERSENSITIVITY. PRACTITIONER, 227 (1376), R4-R6.
Rook, G.A. (1983). Immunity and hypersensitivity.. The Practitioner, 227 (1376), iv-vi.
Stanford, J.L., Rook, G.A. (1983). Protection from infection with mycobacteria.. The Indian journal of chest diseases & allied sciences, 25 (2), 132-138.
Nye, P.M., Price, J.E., Revankar, C.R., Rook, G.A., Stanford, J.L. (1983). The demonstration of two types of suppressor mechanism in leprosy patients and their contacts by quadruple skin-testing with mycobacterial reagent mixtures.. LEPROSY REVIEW, 54 (1), 9-18.
Rook, G.A. (1983). The immunology of leprosy.. TUBERCLE, 64 (4), 297-312. doi:10.1016/0041-3879(83)90028-4

1982

Bahr, G.M., Modabber, F.Z., Rook, G.A., Mehrotra, M.L., Stanford, J.L., Chedid, L. (1982). Absence of antibodies to muramyl dipeptide in patients with tuberculosis or leprosy.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 47 (1), 53-58.
ROOK, G.A.W., RAINBOW, S. (1982). AN ISOTOPE INCORPORATION ASSAY FOR THE ANTI-MYCOBACTERIAL EFFECTS OF HUMAN-MONOCYTES. ANNALES DE MICROBIOLOGIE, B133 (1), 169.
Rook, G.A. (1982). Suppressor cells of mouse and man. What is the evidence that they contribute to the aetiology of the mycobacterioses?. LEPROSY REVIEW, 53 (4), 306-312.
Fleming, B., Rook, G.A. (1982). T-cell-dependent polyclonal activation by soluble mycobacterial extracts of B cells in peripheral blood mononuclear cell populations from leprosy patients and normal donors.. IMMUNOLOGY, 47 (4), 589-595.

1981

Stanford, J.L., Nye, P.M., Rook, G.A., Samuel, N., Fairbank, A. (1981). A preliminary investigation of the responsiveness or otherwise of patients and staff of a leprosy hospital to groups of shared or species antigens of mycobacteria.. LEPROSY REVIEW, 52 (4), 321-327.
Rook, G.A., Cameron, C.H. (1981). An inexpensive, portable, battery-operated photometer for the reading of ELISA tests in microtitration plates.. JOURNAL OF IMMUNOLOGICAL METHODS, 40 (1), 109-114. doi:10.1016/0022-1759(81)90086-7
ROOK, G.A.W., RAINBOW, S. (1981). AN ISOTOPE INCORPORATION ASSAY FOR THE ANTI-MYCOBACTERIAL EFFECTS OF HUMAN-MONOCYTES. ANNALES D IMMUNOLOGIE, D132 (2-3), 281-289.
Ebringer, R., Rook, G., Swana, G.T., Bottazzo, G.F., Doniach, D. (1981). Autoantibodies to cartilage and type II collagen in relapsing polychondritis and other rheumatic diseases.. ANNALS OF THE RHEUMATIC DISEASES, 40 (5), 473-479. doi:10.1136/ard.40.5.473
Rook, G.A. (1981). Chromosomes for the enzyme-linked immunosorbent assay (ELISA) using horse-radish peroxidase.. LEPROSY REVIEW, 52 (3), 281-283.
Stanford, J.L., Shield, M.J., Rook, G.A. (1981). How environmental mycobacteria may predetermine the protective efficacy of BCG.. TUBERCLE, 62 (1), 55-62. doi:10.1016/0041-3879(81)90037-4
Bahr, G.M., Rook, G.A., Stanford, J.L. (1981). Inhibition of the proliferative response of peripheral blood lymphocytes to mycobacterial or fungal antigens by co-stimulation with antigens from various mycobacterial species.. IMMUNOLOGY, 44 (3), 593-598.
ROOK, G.A.W. (1981). MODULATION OF THE RESPONSE TO PATHOGENIC MYCOBACTERIA BY CONTACT WITH ENVIRONMENTAL SPECIES. JOURNAL OF MEDICAL MICROBIOLOGY, 14 (2), R6.
Bahr, G.M., Rook, G.A., Stanford, J.L. (1981). Prostaglandin-dependent regulation of the in vitro proliferative response to mycobacterial antigens of peripheral blood lymphocytes from normal donors and from patients with tuberculosis or leprosy.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 45 (3), 646-653.
Bahr, G.M., Rook, G.A., Stanford, J.L., Lydyard, P.M., Bryceson, A.D. (1981). The effect of delayed addition of antigen and 'E' rosetting on the proliferative response to mycobacterial antigens of peripheral blood lymphocytes from normal individuals or from patients with tuberculosis or leprosy.. IMMUNOLOGY, 44 (3), 585-591.
Rook, G.A., Bahr, G.M., Stanford, J.L. (1981). The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG.. TUBERCLE, 62 (1), 63-68. doi:10.1016/0041-3879(81)90038-6
ROOK, G.A.W., STANFORD, J.L. (1981). THE HETEROGENEITY OF THE IMMUNE-RESPONSE TO MYCOBACTERIA AND THE RELEVANCE OF THE COMMON ANTIGENS TO THEIR PATHOGENICITY. ANNALES D IMMUNOLOGIE, D132 (2-3), 155-164.

1980

Stanford, J.L., Rook, G.A., Samuel, N., Madlener, F., Khamenei, A.A., Nemati, T., ...Rees, R.J. (1980). Preliminary immunological studies in search of correlates of protective immunity carried out on some Iranian leprosy patients and their families.. LEPROSY REVIEW, 51 (4), 303-314.
Rook, G.A. (1980). The immunogenicity of killed mycobacteria.. LEPROSY REVIEW, 51 (4), 295-301.
Bahr, G.M., Rook, G.A., Moreno, E., Lydyard, P.M., Modabber, F.Z., Stanford, J.L. (1980). Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE.. IMMUNOLOGY, 41 (4), 865-873.

1979

ROOK, G.A.W., STANFORD, J.L., SHIELD, M.J., SAMUEL, N.M. (1979). CHARACTERIZATION IN MOUSE AND MAN OF 2 DISTINCT FORMS OF DELAYED SKIN-TEST RESPONSE, RELEVANT TO MYCOBACTERIAL INFECTIONS. INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 47 (2), 377.
SAMUEL, N.M., STANFORD, J.L., ROOK, G.A.W. (1979). INVESTIGATION OF MECHANISMS REGULATING SKIN-TEST RESPONSIVENESS IN LEPROSY PATIENTS USING SOLUBLE MYCOBACTERIUM-LEPRAE AND M-TUBERCULOSIS ANTIGENS AND A MIXTURE OF THE 2. INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 47 (2), 385-386.
STANFORD, J.L., SHIELD, M.J., ROOK, G.A.W. (1979). MYCOBACTERIUM-LEPRAE, OTHER MYCOBACTERIA AND A POSSIBLE VACCINE. INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 47 (2), 357.
SHIELD, M.J., STANFORD, J.L., ROOK, G.A.W. (1979). REASON FOR THE REDUCTION OF THE PROTECTIVE EFFICACY OF BCG IN BURMA. INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 47 (2), 319-320.
Rook, G.A., Stanford, J.L. (1979). The relevance to protection of three forms of delayed skin-test response evoked by m. leprae and other mycobacteria in mice. Correlation with the classical work in the guinea-pig.. Parasite immunology, 1 (2), 111-123. doi:10.1111/j.1365-3024.1979.tb00699.x

1978

Rook, G.A., King, J. (1978). Is the adherent, non-specific 'suppressor' cell from rodent spleens an in vitro artefact?. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 32 (3), 466-470.
Rook, G.A. (1978). Three forms of delayed skin-test response evoked by mycobacteria.. NATURE, 271 (5640), 64-65. doi:10.1038/271064a0

1977

SHIELD, M.J., STANFORD, J.L., ROOK, G.A.W. (1977). INVESTIGATION OF IMMUNOLOGICAL SPECTRUM OF MYCOBACTERIAL DISEASE IN MAN. JOURNAL OF MEDICAL MICROBIOLOGY, 10 (2), R3.
ROOK, G.A.W., STANFORD, J.L., SHIELD, M.J. (1977). INVESTIGATION OF MECHANISMS RESPONSIBLE FOR SPECTRUM OF IMMUNOLOGICAL RESPONSE TO MYCOBACTERIAL DISEASE IN MOUSE. JOURNAL OF MEDICAL MICROBIOLOGY, 10 (2), R3.

1976

Rook, G.A. (1976). Immune responses to mycobacteria in mice and men.. PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 69 (6), 442-444. doi:10.1177/003591577606900618
Rook, G.A., Carswell, J.W., Stanford, J.L. (1976). Preliminary evidence for the trapping of antigen-specific lymphocytes in the lymphoid tissue of 'anergic' tuberculosis patients.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 26 (1), 129-132.
Stanford, J.L., Rook, G.A. (1976). Taxonomic studies on the leprosy bacillus.. INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 44 (1-2), 216-221.
Rook, G.A., Stewart-Tull, D.E. (1976). The dissociation of adjuvant properties of mycobacterial components from mitogenicity, and from the ability to induce the release of mediators from macrophages.. IMMUNOLOGY, 31 (3), 389-396.

1975

ROOK, G.A.W., KING, J. (1975). POSSIBLE ROLE OF MACROPHAGE IN SUPPRESSION OF CELL-MEDIATED-IMMUNITY IN SEVERE MYCOBACTERIAL INFECTIONS. JOURNAL OF MEDICAL MICROBIOLOGY, 8 (2), PR9.
Stanford, J.L., Rook, G.A., Convit, J., Godal, T., Kronvall, G., Rees, R.J., Walsh, G.P. (1975). Preliminary taxonomic studies on the leprosy bacillus.. BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY, 56 (6), 579-585.
Rook, G.A. (1975). The immunological consequences of antigen overload in experimental mycobacterial infections of mice.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 19 (1), 167-177.
Rook, G.A. (1975). The potentiating, mitogenic and inhibitory effects on lymphocytes in vitro, of macrophages in the lymph nodes of mice 'overloaded' with mycobacterial products.. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 21 (1), 163-172.

1973

ROOK, G.A.W. (1973). IS MACROPHAGE SITE OF IMMUNOSUPPRESSIVE ACTION OF RIFAMPICIN. TUBERCLE, 54 (4), 291-295. doi:10.1016/S0041-3879(73)80032-7
Rook, G.A. (1973). Is the macrophage the site of the immunosuppressive action of rifampicin?. Tubercle, 54 (4), 291-295. doi:10.1016/s0041-3879(73)80032-7

1972

Stanfcrd, J.L., Brook, A.S., Shepherd, M., Bannerman, C., Todd, P.J., Aspinall, J.S., ...Smith, D.W. (1972). Erasures from the “Register”. British Medical Journal, 4 (5837), 423-424. doi:10.1136/bmj.4.5837.423-a

1970

Rook, G.A., Webb, H.E. (1970). Antilymphocyte serum and tissue culture used to investigate role of cell-mediated response in viral encephalitis in mice.. BRITISH MEDICAL JOURNAL, 4 (5729), 210-&. doi:10.1136/bmj.4.5729.210

1968

Rook, G.A., Cater, D.B. (1968). The effect of lymph-node cells from specifically sensitised mice, on the growth of the BP8 ascites tumor "in vivo" and "in vitro".. BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY, 49 (3), 241-&.

1964

SANTOPADRE, G., RUSCHI, A., BENDINELLI, M., ROOK, G.A. (1964). [ON THE ANTIBODY RESPONSE TO ANTIPOLIOMYELITIC VACCINE (SABIN TYPE) IN A GROUP OF CHILDREN OF THE PROVINCE OF PISA].. Rivista italiana d'igiene, 24 571-582.

1900

Rook, G.A.W., Doherty, T.M. (1900). Host susceptibility and resistance to M.tuberculosis:. In Zumla, A., Schaaf, A. (Eds.), Genetic neuroendocrine and acquired factors. London: Elsevier.
Rook, G.A.W. (1900). The broader implications of the hygiene hypothesis. Immunology,
Rook, G.A.W., Hernandez-Pando, R., Zumla, A. (1900). Tuberculosis due to high-dose challenge in partially immune individuals:a problem for vaccination?. The Journal of Infectious Diseases,